10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 ____________________________________________________________ 

FORM 10-Q

 ____________________________________________________________ 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 26, 2020

OR

 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE PERIOD FROM             TO             .

Commission File Number 0-11559

 ____________________________________________________________ 

KEY TRONIC CORPORATION

(Exact name of registrant as specified in its charter)

 ____________________________________________________________ 

Washington	91-0849125
(State of Incorporation)	(I.R.S. Employer Identification No.)

N. 4424 Sullivan Road

Spokane Valley, Washington 99216

(509) 928-8000

  ____________________________________________________________ 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements during the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated Filer	☐	Accelerated Filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, no par value	KTCC	NASDAQ Global Market

As of November 3, 2020, 10,759,680 shares of common stock, no par value (the only class of common stock), were outstanding.

KEY TRONIC CORPORATION

Index

		Page No.
PART I.	FINANCIAL INFORMATION:
Item 1.	Financial Statements (Unaudited):	3
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Income	4
	Condensed Consolidated Statements of Comprehensive Income	5
	Condensed Consolidated Statements of Cash Flows	6
	Condensed Consolidated Statements of Shareholders’ Equity	7
	Notes to Condensed Consolidated Financial Statements	8-17
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18-28
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	29
Item 4.	Controls and Procedures	29
PART II.	OTHER INFORMATION:
Item 1.	Legal Proceedings	30
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds*
Item 3.	Defaults upon Senior Securities*
Item 4.	Mine Safety Disclosures*
Item 5.	Other Information*
Item 6.	Exhibits	30
Signatures		31

 * Items are not applicable

“We,” “us,” “our,” “Company,” and “KeyTronic,” unless the context otherwise requires, means Key Tronic Corporation and its subsidiaries.

PART I: FINANCIAL INFORMATION

Item 1: Financial Statements

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands; except share data)

	September 26, 2020		June 27, 2020
ASSETS
Current assets:
Cash and cash equivalents	$	1,471	$	553
Trade receivables, net of allowance for doubtful accounts of $609 and $609	91,563		86,123
Contract assets	24,458		23,753
Inventories, net	119,791		115,020
Other	18,782		17,315
Total current assets	256,065		242,764
Property, plant and equipment, net	33,316		31,764
Operating lease right-of-use assets, net	16,370		17,568
Other assets:
Deferred income tax asset	9,632		10,178
Other	2,429		2,587
Total other assets	12,061		12,765
Total assets	$	317,812	$	304,861
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	79,146	$	80,204
Accrued compensation and vacation	7,641		10,428
Current portion of debt, net	906		7,508
Other	13,957		14,079
Total current liabilities	101,650		112,219
Long-term liabilities:
Term loans	4,021		3,258
Revolving loan	80,414		60,094
Operating lease liabilities	11,502		12,624
Deferred income tax liability	232		234
Other long-term obligations	1,386		875
Total long-term liabilities	97,555		77,085
Total liabilities	199,205		189,304
Commitments and contingencies (Note 9)
Shareholders’ equity:
Common stock, no par value—shares authorized 25,000; issued and outstanding 10,760 and 10,760 shares, respectively	47,009		46,946
Retained earnings	71,830		70,111
Accumulated other comprehensive income (loss)	(232)		(1,500)
Total shareholders’ equity	118,607		115,557
Total liabilities and shareholders’ equity	$	317,812	$	304,861

See accompanying notes to consolidated financial statements.

3

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited, in thousands, except share and per share amounts)

	Three Months Ended
	September 26, 2020		September 28, 2019
Net sales	$	123,207	$	105,285
Cost of sales	113,192		96,012
Gross profit	10,015		9,273
Research, development and engineering expenses	2,245		1,660
Selling, general and administrative expenses	4,974		5,074
Total operating expenses	7,219		6,734
Operating income	2,796		2,539
Interest expense, net	681		710
Income before income taxes	2,115		1,829
Income tax provision	396		277
Net income	$	1,719	$	1,552
Net income per share — Basic	$	0.16	$	0.14
Weighted average shares outstanding — Basic	10,760		10,760
Net income per share — Diluted	$	0.16	$	0.14
Weighted average shares outstanding — Diluted	11,040		10,805

See accompanying notes to consolidated financial statements.

4

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited, in thousands)

	Three Months Ended
	September 26, 2020		September 28, 2019
Comprehensive income:
Net income	$	1,719	$	1,552
Other comprehensive income:
Unrealized gain (loss) on hedging instruments, net of tax	1,268		(947)
Comprehensive income	$	2,987	$	605

Other comprehensive income for the three months ended September 26, 2020 and September 28, 2019, is reflected net of tax expense (benefit) of approximately $1.5 million and $(0.3) million, respectively.

See accompanying notes to consolidated financial statements.

5

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited, in thousands)

	Three Months Ended
	September 26, 2020		September 28, 2019
Operating activities:
Net income	$	1,719	$	1,552
Adjustments to reconcile net income to cash used in operating activities:
Depreciation and amortization	1,752		1,609
Amortization of deferred loan costs	13		8
Provision for obsolete inventory	178		21
Provision for warranty	19		16
Loss on disposal of assets	—		206
Share-based compensation expense	63		74
Deferred income taxes	(81)		(360)
Changes in operating assets and liabilities:
Trade receivables	(5,449)		(10,140)
Contract assets	(705)		399
Inventories	(4,949)		(17,327)
Other assets	292		(829)
Accounts payable	(1,059)		13,643
Accrued compensation and vacation	(2,787)		600
Other liabilities	1,555		215
Cash used in operating activities	(9,439)		(10,313)
Investing activities:
Purchase of property and equipment	(3,186)		(3,046)
Proceeds from sale of fixed assets	—		696
Cash receipts from deferred purchase price of factored receivables	—		1,079
Cash used in investing activities	(3,186)		(1,271)
Financing activities:
Payment of financing costs	(307)		(2)
Proceeds from issuance of long term debt	5,000		5,000
Interest rate swap termination fee	(925)		—
Repayments of long term debt	(10,842)		(1,468)
Borrowings under revolving credit agreement	45,975		45,799
Repayments of revolving credit agreement	(25,358)		(37,842)
Cash provided by financing activities	13,543		11,487
Net increase (decrease) in cash and cash equivalents	918		(97)
Cash and cash equivalents, beginning of period	553		601
Cash and cash equivalents, end of period	$	1,471	$	504
Non-cash investing activities:
Beneficial interest in transferred receivables	(9)		(1,788)
Supplemental cash flow information:
Interest payments	$	578	$	593
Income tax payments, net of refunds	$	351	$	213

See accompanying notes to consolidated financial statements.

6

KEY TRONIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(Unaudited, in thousands; except share data)

	Three Months Ended
	September 26, 2020		September 28, 2019
Total shareholders’ equity, beginning balances	$	115,557	$	114,459
Common stock (shares):
Beginning balances	$	10,760	$	10,760
Exercise of stock appreciation rights	—		—
Ending balances	10,760		10,760
Common stock:
Beginning balances	$	46,946	$	46,680
Share-based compensation	63		74
Ending balances	47,009		46,754
Retained Earnings:
Beginning balances	$	70,111	$	65,353
Net income	1,719		1,552
Ending balances	71,830		66,905
Accumulated other comprehensive income:
Beginning balances	$	(1,500)	$	2,426
Unrealized gain (loss) on hedging instruments, net	1,268		(947)
Ending balances	(232)		1,479
Total shareholders’ equity, ending balances	$	118,607	$	115,138

See accompanying notes to consolidated financial statements.

7

KEY TRONIC CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1.Basis of Presentation

The consolidated financial statements included herein have been prepared by Key Tronic Corporation and subsidiaries (the Company) pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in our annual consolidated financial statements have been condensed or omitted. The year-end condensed consolidated balance sheet information was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 27, 2020.

The Company’s reporting period is a 52/53 week fiscal year ending on the Saturday closest to June 30. The three month period ended September 26, 2020 and September 28, 2019, were 13 week periods. Fiscal year 2021 will end on July 3, 2021, which is a 53 week year. Fiscal year 2020 which ended on June 27, 2020, was a 52 week year.

Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)

Due to the COVID-19 pandemic, the Company has seen extreme shifts in demand from its customer base. The possibility of future temporary closures, as well as adverse fluctuations in customer demand, freight and expedite costs, precautionary safety expenses and labor shortages, collectability of accounts, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results. Additionally, continued adverse macroeconomic conditions and significant currency exchange fluctuations can also materially impact operating results.

2.Significant Accounting Policies

Earnings Per Common Share

Basic earnings per common share (EPS) is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing net income (loss) by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of equity awards were used to repurchase common shares at the average market price during the period. The computation of diluted EPS does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on EPS.

Derivative Instruments and Hedging Activities

The Company has entered into foreign currency forward contracts that are accounted for as cash flow hedges in accordance with ASC 815, “Derivatives and Hedging”. The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative’s effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item.

The Company uses derivatives to manage the variability of foreign currency fluctuations of expenses in our Mexico facilities. The foreign currency forward contracts have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded.

The Company’s foreign currency forward contracts potentially expose the Company to credit risk to the extent the counterparty may be unable to meet the terms of the agreement. The Company minimizes such risk by utilizing a counterparty with a strong credit rating. The Company’s counterparty to the foreign currency forward contracts is a major banking institution. This institution does not require collateral for the contracts, and the Company believes that the risk of the counterparty failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes.

8

Income Taxes

We compute our interim income tax provision through the use of an estimated annual effective tax rate (ETR) applied to year-to-date operating results and specific events that are discretely recognized as they occur. In determining the estimated annual ETR, we analyze various factors, including projections of our annual earnings, taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, our ability to use tax credits and available tax planning alternatives. Discrete items, including the effect of changes in tax laws, tax rates, and certain circumstances with respect to valuation allowances or other unusual or non-recurring tax adjustments, are reflected in the period in which they occur as an addition to, or reduction from, the income tax provision, rather than included in the estimated annual ETR.

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized.

We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. The tax years 1998 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject. Refer to Note 6 for further discussions.

Recently Issued Accounting Standards

In March of 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments, which clarifies specific issues raised by stakeholders. Specifically, the ASU clarifies the following: 1) that all entities are required to provide the fair value option disclosures in ASC 825, Financial Instruments 2) clarifies that the portfolio exception in ASC 820, Fair Value Measurement, applies to nonfinancial items accounted for as derivatives under ASC 815, Derivatives and Hedging; 3) clarifies that for purposes of measuring expected credit losses on a net investment in a lease in accordance with ASC 326, Financial Instruments - Credit Losses, the lease term determined in accordance with ASC 842, Leases, should be used as the contractual term; 4) clarifies that when an entity regains control of financial assets sold, it should recognize an allowance for credit losses in accordance with ASC 326; and 5) aligns the disclosure requirements for debt securities in ASC 320, Investments - Debt Securities, with the corresponding requirements for depository and lending institutions in ASC 942, Financial Services - Depository and Lending. The amendments in the ASU have various effective dates and transition requirements which are dependent on timing of adoption of ASU 2016-13. The Company is currently assessing the effects on its consolidated financial statements, and it intends to adopt the guidance as they become effective.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), which modifies certain provisions of ASC 740, Income Taxes, in an effort to reduce the complexity of accounting for income taxes. ASU 2019-12 is effective for the Company the first quarter of fiscal year 2022. We are currently evaluating the effects and do not believe this standard will have a material impact on our consolidated financial position, results of operations, or cash flows.

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance is effective for the Company beginning in the first quarter of fiscal year 2024 with early adoption permitted. The Company is currently assessing the impact on its consolidated financial statements, and it intends to adopt the guidance when it becomes effective in the first quarter of fiscal year 2024.

9

3.Inventories

The components of inventories consist of the following (in thousands):

	September 26, 2020		June 27, 2020
Finished goods	$	15,632	$	15,269
Work-in-process	21,418		17,390
Raw materials and supplies	82,741		82,361
	$	119,791	$	115,020

Total inventory as of September 26, 2020 is net of $14.5 million of reserves, customer payments, and customer deposits compared to $17.3 million in reserves, customer payments, and customer deposits as of June 27, 2020.

4.Long-Term Debt

On August 14, 2020, the Company entered into a loan agreement with Bank of America. The Loan Agreement replaces the Company’s prior amended and restated credit agreement, as amended, with Wells Fargo Bank. The Loan Agreement provides for a five-year asset-based senior secured revolving credit facility of up to $93 million, maturing on August 14, 2025. As of September 26, 2020, the Company had an outstanding balance under the asset-based revolving credit facility of $80.7 million and $12.3 million available for future borrowings.

As of June 27, 2020, the Company had an outstanding balance under the credit facility with Wells Fargo Bank of $60.1 million, $0.4 million in outstanding letters of credit and $4.5 million available for future borrowings. The Company had an outstanding balance of $10.0 million under the term loan with Wells Fargo Bank as of June 27, 2020.

On August 14, 2020, the Company also entered into a $5.0 million equipment financing facility relating to the Company’s existing U.S. manufacturing equipment that bears interest at 4.85% and matures on August 14, 2025. Under this loan agreement, equal monthly payments of approximately $94,000 commenced on September 14, 2020 and will continue through the maturity of the equipment financing facility on August 14, 2025. As of September 26, 2020, the Company had an outstanding balance of $4.9 million. As of June 27, 2020, the Company had an outstanding balance of $0.9 million under the Wells Fargo Bank equipment term loan agreement.

The interest rates on outstanding debt as of September 26, 2020 range from 3.00% - 4.85% compared to 2.17% - 2.18% as of June 27, 2020.

Generally, the interest rate applicable to loans under the loan agreement will be, at the Company’s option: (i)(A) the base rate which is the highest of (1) the prime rate for the applicable day (as such rate is determined from time to time by the Bank), (2) the federal funds rate for the applicable day plus 0.50%, and (3) LIBOR for a 30-day interest period as of the applicable day plus 1.00% (provided that in no event shall the base rate be less than zero), plus the applicable interest margin for base rate loans; and (B) LIBOR rate for an applicable interest period (provided that in no event shall the LIBOR rate be less than 0.50%), plus the applicable interest margin for LIBOR rate loans. Depending on average daily excess borrowing availability over applicable periods under the Credit Facility, applicable interest margins on: (x) base rate loans will be 1.25-1.75%; and (y) LIBOR rate loans will be 2.25-2.75%, resetting on a quarterly basis beginning in early 2021. If there is an event of default under the loan agreement, all loans and other obligations will bear interest at a rate of an additional 2.00% on the otherwise applicable interest rates. In addition to interest charges, the Company is required to pay a fee of 0.25% per annum on the unused portion of the Credit Facility, monthly in arrears.

Under the new loan agreement with Bank of America, the asset-based revolving credit facility bears interest at LIBOR plus 2.5%, as elected by the Company.

10

Debt maturities as of September 26, 2020 for the next five years and thereafter are as follows (in thousands):

Fiscal Years Ending	Amount
2021 (1)	$	678
2022	943
2023	989
2024	1,039
2025	1,090
Thereafter	80,899
Total debt	$	85,638
Unamortized debt issuance costs	(297)
Long-term debt, net of debt issuance costs	$	85,341

    (1) Represents scheduled payments for the remaining nine-month period ending July 3, 2021.

The Company must comply with certain financial covenants, including a fixed charge coverage ratio and a cash flow leverage ratio. The credit agreement requires the Company to grant certain inspection rights to the Bank, limit or restrict the Company’s cash management; limit or restrict the ability of the Company to incur additional liens, make acquisitions or investments, incur additional indebtedness, engage in mergers, consolidations, liquidations, dissolutions, or dispositions, pay dividends or other restricted payments, prepay certain indebtedness, engage in transactions with affiliates, and use proceeds. The Company was in compliance with all financial covenants as of September 26, 2020.

5.Trade Accounts Receivable Purchase Programs

Sale Programs

The Company has utilized an Account Purchase Agreement with Wells Fargo Bank, N.A. (“WFB”) which allowed the Company to sell and assign to WFB and WFB to purchase from the Company the accounts receivable of certain Company customers in a maximum aggregate amount outstanding of $25.0 million. As of September 26, 2020, the Company had no factored receivables with WFB.

The Company did not sell any accounts receivables during the three months ended September 26, 2020. Total accounts receivables sold during the three months ended September 28, 2019 was approximately $17.8 million. Accounts receivables sold and not yet collected was $9,000 as of June 27, 2020. The receivables that were sold were removed from the condensed consolidated balance sheets and the cash received is reflected as cash provided by operating activities in the condensed consolidated statements of cash flows. Cash receipts related to the deferred purchase price from receivables factored by the Company is reflected as cash provided by investing activities.

6.Income Taxes

The Company expects to repatriate a portion of its foreign earnings based on increased net sales growth driving additional capital requirements domestically, cash requirements for potential acquisitions and to implement certain tax strategies. The Company currently expects to repatriate approximately $8.0 million of foreign earnings in the future. All other unremitted foreign earnings are expected to remain permanently reinvested for planned fixed assets purchases and improvements in foreign locations.

Repatriations of cash will generally be tax-free in the U.S. However, withholding taxes in China may still apply to any such future repatriations. Management has not changed its indefinite investment assertions with regard to the portion of accumulated earnings and profits in China that may be repatriated in the future. Accordingly, management estimates that future repatriations of cash from China may result in approximately $0.8 million of withholding tax. There would be no offsetting foreign tax credits in the U.S. and as such, this potential liability is a direct cost associated with actual repatriations. Withholding taxes will not apply to future repatriations from Mexico or Vietnam.

The Company has available approximately $8.7 million of gross federal research and development tax credits as of September 26, 2020. ASC 740 requires the Company to recognize in its financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. Accordingly, as of September 26, 2020, the Company has recorded $2.9 million of unrecognized tax benefits associated with these federal tax credits, resulting in a net deferred tax benefit of approximately $5.8 million.

11

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits net operating loss (NOL) carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The Company does not expect that the NOL carryback provision of the CARES Act will result in a material cash benefit. In addition, the CARES Act contains modifications on the limitation of business interest for tax years beginning in 2019 and 2020. The modifications to Section 163(j) increase the allowable business interest deduction from 30% of adjusted taxable income to 50% of adjusted taxable income. This modification (in connection with related modifications included in final regulations issued in the first quarter of fiscal year 2021) would increase the allowable interest expense deduction of the Company and result in less taxable income for fiscal years 2020 and 2021, but is not expected to have a material impact on the provision for income taxes. Also, under the CARES Act, AMT credits not previously refunded for the 2018 tax year are refundable in the 2019 taxable year rather than in years 2019-2021, and taxpayers can elect to claim 100% of the AMT credits in the first taxable year beginning in 2018 by applying for a tentative refund claim on or before December 31, 2020. The Company made this election by applying for a tentative refund claim in the fourth quarter of fiscal year 2020. The Company is continuing to evaluate the impacts of other aspects of the CARES Act, and at this time the Company does not believe they will have a material impact on our consolidated financial position, results of operations, or cash flows.

7.Earnings Per Share

The following table presents a reconciliation of the denominator in the basic and diluted EPS calculation and the number of antidilutive common share awards that were not included in the diluted earnings per share calculation. These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period.

	Three Months Ended
	(in thousands, except share and per share information)
	September 26, 2020		September 28, 2019
Net income	$	1,719	$	1,552
Weighted average shares outstanding—basic	10,760		10,760
Effect of dilutive common stock awards	280		45
Weighted average shares outstanding—diluted	11,040		10,805
Net income per share—basic	$	0.16	$	0.14
Net income per share—diluted	$	0.16	$	0.14
Antidilutive SARs not included in diluted earnings per share	329		940

8. Share-based Compensation

The Company’s incentive plan provides for equity and liability awards to employees and non-employee directors in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold, research, development and engineering, and selling, general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations.

In addition to service conditions, SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are evaluated quarterly to determine the likelihood that performance metrics will be achieved during the performance period. These awards are charged to compensation expense over the requisite service period based on the number of shares expected to vest. The SARs cliff vest after a three-year period from date of grant and expire five years from date of grant.

The grant date fair value for the awards granted below were estimated using the Black Scholes option valuation method:

	July 23, 2020		July 26, 2019
SARs Granted	155,000		175,000
Strike Price	$	6.94	$	4.93
Fair Value	$	2.32	$	1.23

Total share-based compensation expense recognized during the three months ended September 26, 2020 and September 28, 2019 was approximately $64,000 and $74,000, respectively.

12

As of September 26, 2020, total unrecognized compensation expense related to unvested share-based compensation arrangements was approximately $0.5 million. This expense is expected to be recognized over a weighted average period of 2.33 years. No SARs were exercised during the three months ended September 26, 2020 or September 28, 2019.

9.Commitments and Contingencies

Litigation and Other Matters

The Company is party to certain lawsuits or claims in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the financial position, results of operations or cash flow of the Company.

Warranties

The Company provides warranties on certain product sales. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. If actual return rates and/or repair and replacement costs differ significantly from management’s estimates, adjustments to recognize additional cost of sales may be required in future periods. The Company’s warranty reserve was approximately $13,000 as of September 26, 2020 and $15,000 as of June 27, 2020, respectively.

10.Derivative Financial Instruments

As of September 26, 2020, the Company had outstanding foreign currency forward contracts with a total notional amount of $30.0 million. The maturity dates for these contracts extend through December 2021. For the three months ended September 26, 2020, the Company did not enter into any foreign currency forward contracts and settled $6.7 million of contracts. During the same period of the previous year, the Company did not enter into any foreign currency forward contracts and settled $6.7 million of contracts.

As of September 26, 2020, the aggregate notional amount of the Company’s outstanding foreign currency contracts along with their unrealized gains (losses) are expected to mature as summarized below (in thousands):

Quarter Ending	Notional Contracts in MXN		Notional Contracts in USD		Estimated Fair Value
December 26, 2020	$	132,773	$	6,241	$	(333)
April 3, 2021	$	148,253	$	6,682	$	(161)
July 3, 2021	$	144,725	$	6,446	$	(134)
October 2, 2021	$	146,373	$	5,502	$	805
January 1, 2022	$	137,973	$	5,129	$	754

On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of September 30, 2022, related to the borrowings outstanding under the term loan with Wells Fargo Bank. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.70% that replaces the one month LIBOR rate component of our contractual interest to be paid to Wells Fargo Bank as part of our term loan. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the term loan, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. At date of termination this interest rate swap was in a liability position of $148,400, which will be amortized to interest expense over the original term of the swap.

On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of November 1, 2023, related to the borrowings outstanding under the line of credit with Wells Fargo Bank. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.67% that replaces the one month LIBOR rate component of our contractual interest to be paid to Wells Fargo Bank as part of our line of credit. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the line of credit, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. At date of termination this interest rate swap was in a liability position of $776,500, which will be amortized to interest expense over the original term of the swap.

13

The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of September 26, 2020 and June 27, 2020 (in thousands):

		September 26, 2020		June 27, 2020
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value		Fair Value
Foreign currency forward contracts	Other current assets	$	771	$	—
Foreign currency forward contracts	Other long-term assets	$	788	$	1,097
Foreign currency forward contracts	Other current liabilities	$	(628)	$	(1,960)
Foreign currency forward contracts	Other long-term liabilities	$	—	$	(17)
Interest rate swap	Other current liabilities	$	—	$	(347)
Interest rate swap	Other long-term liabilities	$	—	$	(610)

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended September 26, 2020 and September 28, 2019, respectively (in thousands):

Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of June 27, 2020		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of September 26, 2020
Forward contracts	Cost of sales	$	(759)	$	1,043	$	359	$	643
Interest rate swap	Interest expense	(741)		(223)		89		(875)
Total		$	(1,500)	$	820	$	448	$	(232)
Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of June 29, 2019		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of September 28, 2019
Forward contracts	Cost of sales	$	2,424	$	(41)	$	(904)	$	1,479
Interest rate swap	Interest expense	2		—		(2)		—
Total		$	2,426	$	(41)	$	(906)	$	1,479

As of September 26, 2020, the net amount of unrealized gain expected to be reclassified into earnings within the next 12 months is approximately $0.1 million. As of September 26, 2020, the Company does not have any foreign exchange contracts with credit-risk-related contingent features.

11.Fair Value Measurements

The Company currently has forward contracts to hedge known future cash outflows for expenses denominated in the Mexican peso. These contracts are measured on a recurring basis based on the foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. There are three levels of fair value hierarchy inputs used to value assets and liabilities which include: Level 1 – inputs are quoted market prices for identical assets or liabilities; Level 2 – inputs other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – inputs are unobservable inputs for the asset or liability. These contracts are marked to market using level 2 input criteria every quarter with the unrealized gain or loss, net of tax, reported as a component of shareholders’ equity in accumulated other comprehensive gain (loss), as they qualify for hedge accounting.

14

The following table summarizes the fair value of assets (liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of September 26, 2020 and June 27, 2020 (in thousands):

	September 26, 2020
	Level 1		Level 2		Level 3		Total Fair Value
Financial Assets:
Foreign currency forward contracts	$	—	$	1,559	$	—	$	1,559
Financial Liabilities:
Foreign currency forward contracts	$	—	$	(628)	$	—	$	(628)

	June 27, 2020
	Level 1		Level 2		Level 3		Total Fair Value
Financial Assets:
Foreign currency forward contracts	$	—	$	1,097	$	—	$	1,097
Financial Liabilities:
Interest rate swap	$	—	$	(957)	$	—	$	(957)
Foreign currency forward contracts	$	—	$	(1,977)	$	—	$	(1,977)

The carrying values of cash and cash equivalents, accounts receivable and current liabilities reflected on the balance sheets at September 26, 2020 and June 27, 2020, reasonably approximate their fair value. The Company’s long-term debt, which is measured at amortized cost, primarily consists of an asset-based revolving credit facility, lease liability, and an equipment loan. These borrowings bear interest at LIBOR plus 2.5% per the loan agreement. Each of these rates is a variable floating rate dependent upon current market conditions and the Company’s current credit risk as discussed in footnote 4.

As a result of the determinable market rates for our asset-based revolving credit facility and equipment loan, they are classified within Level 2 of the fair value hierarchy. Further, the carrying value of each of these instruments reasonably approximates their fair value as of September 26, 2020 and June 27, 2020.

12.Revenue

Revenue Recognition

The Company specializes in services ranging from product manufacturing to engineering and tooling services. The first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outlines the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the Company considers its contract with a customer to be the combination of the MSA and the purchase order. The transaction price is fixed and set forth in each purchase order. In the Company's normal course of business, there are no variable pricing components, or material amounts refunded to customers in the form of refunds or rebates.

15

The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed.

The Company’s typical payment terms are 30 to 90 days and its sales arrangements do not contain any significant financing component for its customers.

The Company generally provides a warranty for workmanship on its manufacturing contracts. Historically, the amount of returns for workmanship issues has been de minimis under the Company’s warranties.

The Company elected to not disclose information about remaining performance obligations as they are part of contracts that that have expected durations of one year or less.

During the first quarter of fiscal year 2021, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods.

Contract Balances

A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice for payment. Contract assets are classified separately on the condensed consolidated balance sheet and transferred to receivables when the right to payment becomes unconditional. The following table summarizes the activity in the Company’s contract assets during the three months ended September 26, 2020 (in thousands):

	Contract Assets
Beginning balance, June 27, 2020	$	23,753
Revenue recognized	120,783
Amounts collected or invoiced	(120,078)
Ending balance, September 26, 2020	$	24,458

Disaggregation of Revenue

The following table presents the Company’s revenue disaggregated for the three months ended September 26, 2020 and September 28, 2019 (in thousands):

	EMS Revenue
Recognition	Three Months Ended
	September 26, 2020		September 28, 2019
Over-Time	$	120,836	$	104,026
Point-in-Time	2,371		1,259
Total	$	123,207	$	105,285

16

13.Leases

The Company has several commitments under operating leases for warehouses, manufacturing facilities, office buildings, and equipment with initial terms that expire at various dates during the next 1 year to 11 years.

The components of lease cost for the three months ended September 26, 2020 were (in thousands): 

Lease cost	Classification	Three Months Ended
Operating lease cost	Cost of sales	$	1,164
Operating lease cost	Selling, general and administrative expenses	338
Total lease cost		$	1,502

Amounts reported in the Consolidated Balance Sheet as of September 26, 2020 were (in thousands, except weighted average lease term and discount rate):

	September 26, 2020
Operating Leases:
Operating lease right of use assets	$	16,370
Operating lease liabilities (1)	16,050
Weighted-average remaining lease term (in years)
Operating leases	6.54
Weighted-average discount rate
Operating leases	4.1		%

(1) The current portion of the total operating lease liabilities of $4.5 million is classified under Other Current Liabilities, resulting in $11.5 million classified under Operating Lease Liabilities in the Long-term Liabilities section of the condensed consolidated balance sheet.

Other information related to leases was as follows (in thousands):

	Three Months Ended
	September 26, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	1,198

Future lease payments under non-cancellable leases as of September 26, 2020 are as follows (in thousands):

Fiscal Years Ending	Operating Leases
2021 (1)	$	3,073
2022	3,373
2023	2,598
2024	2,004
2025	1,894
Thereafter	5,673
Total undiscounted lease payments	18,615
Less: present value discount	(2,565)
Total lease liabilities	$	16,050

(1) Represents estimated lease payments for the remaining nine-month period ending July 3, 2021.

17

Management’s Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING STATEMENTS

References in this report to “the Company,” “Key Tronic,” “we,” “our,” or “us” mean Key Tronic Corporation together with its subsidiaries, except where the context otherwise requires.

This Quarterly Report contains forward-looking statements in addition to historical information. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties that might cause such differences include, but are not limited to those outlined in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Risks and Uncertainties that May Affect Future Results.” Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management’s opinions only as of the date hereof. The Company undertakes no obligation to update forward-looking statements to reflect developments or information obtained after the date hereof and disclaims any obligation to do so. Readers should carefully review the risk factors described in periodic reports the Company files from time to time with the Securities and Exchange Commission, including Year-end Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Overview

Key Tronic is a leading contract manufacturer offering value-added design and manufacturing services from its facilities in the United States, Mexico, China and Vietnam. The Company provides its customers full engineering services, materials management, worldwide manufacturing facilities, assembly services, in-house testing, and worldwide distribution. Its customers include some of the world’s leading original equipment manufacturers. Our combined capabilities and vertical integration are proving to be a desirable offering to our expanded customer base.

Our international production capability provides our customers with benefits of improved supply-chain management, reduced inventories, lower transportation costs, and reduced product fulfillment time. We continue to make investments in all of our operating facilities to give us the production capacity, capabilities and logistical advantages to continue to win new business. The following information should be read in conjunction with the consolidated financial statements included herein and with Part II Item 1A, Risk Factors included as part of this filing.

Our mission is to provide our customers with superior manufacturing and engineering services at the lowest total cost for the highest quality products, and create long-term mutually beneficial business relationships by employing our “Trust, Commitment, Results” philosophy.

Executive Summary

For the first quarter of fiscal year 2021, the Company reported total revenue of $123.2 million, up 17% from $105.3 million in the same period of fiscal year 2020.

During the first quarter of fiscal 2021, we won new programs involving audio and video editing systems, indoor air quality, utility meters, warehouse management, and automation technologies.

The concentration of our top three customers’ net sales decreased slightly to 36.8 percent of total sales in the first quarter of fiscal year 2021 from 37.0 percent in the same period of the prior fiscal year.

Net sales to our largest customers may vary significantly from quarter to quarter depending on the size and timing of customer program commencement, forecasts, delays, and design modifications. We remain dependent on continued net sales to our significant customers and most contracts with customers are not firm long-term purchase commitments. We seek to maintain flexibility in production capacity by employing skilled temporary and short-term labor and by utilizing short-term leases on equipment and manufacturing facilities. In addition, our capacity and core competencies for printed circuit board assemblies, precision molding, sheet metal fabrication, tool making, assembly, and engineering can be applied to a wide variety of products.

Gross profit as a percent of net sales was 8.1 percent for the first quarter of fiscal year 2021 as compared to 8.8 percent for the same quarter of the prior fiscal year. The decrease in gross profit as a percentage of net sales was primarily a result of additional costs caused by the COVID-19 crisis. These expenses are related to increased compensation at the Company’s Juarez facility in order to reduce turnover of available employees, as well as preventative measures and equipment for employees at all of its facilities in the US, Mexico, China and Vietnam.

Operating income as a percentage of net sales was 2.3 percent for the first quarter of fiscal year 2021 compared to 2.4 percent of operating income as a percentage of net sales for the first quarter of fiscal year 2020. The decrease in operating income as a percentage of net sales was primarily driven by increased expenses related to the COVID-19 pandemic as discussed above.

Net income for the first quarter of fiscal year 2021 was $1.7 million or $0.16 per share, as compared to net income of $1.6 million or $0.14 per share for the first quarter of fiscal year 2020.

18

We’re pleased with the successful launch of new programs, rebounding customer demand and our strong revenue growth in the first quarter of fiscal 2021. We are ramping recent program wins and, while some of our legacy customers continued to have reduced demand due to the pandemic and related economic slowdown, several have increased demand during the first quarter of fiscal 2021, including programs for healthcare, industrial controls, and telecommunications. During the first quarter of fiscal 2021, we won new programs involving audio and video editing systems, indoor air quality, utility meters, warehouse management, and automation technologies.

Moving into the second quarter of fiscal 2021, the COVID-19 crisis continues to present macroeconomic uncertainty and multiple business challenges, but we continue to see the favorable trend of contract manufacturing returning to North America. We remain focused on protecting the health of all of our employees by adhering to current health guidelines, as well as increasing retention of available employees. We expect continued strong revenue growth in the second quarter and continue to invest in new capacity to prepare for long-term growth.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic.  The Company is continuing to evaluate the CARES Act, and at this time does not believe it will have a material impact on our consolidated financial position, results of operations, or cash flows. Refer to footnote 6 Income Taxes for discussion.

We maintain a strong balance sheet with a current ratio of 2.5 and a debt to equity ratio of 0.7 as of September 26, 2020. Total cash used in operating activities as defined on our cash flow statement was $9.4 million for the three months ended September 26, 2020. We maintain sufficient liquidity for our expected future operations and had $80.7 million in borrowings on our revolving credit facility of which $12.3 million remained available at September 26, 2020.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities. These estimates and assumptions are based on historical results as well as future expectations. Actual results could vary from our estimates and assumptions.

The accounting policies and estimates listed below are those that we believe are the most critical to our consolidated financial condition and results of operations. They are also the accounting policies that typically require our most difficult, subjective and complex judgments and estimates, often for matters that are inherently uncertain.

•Revenue Recognition

•Inactive, Obsolete, and Surplus Inventory Reserve

•Allowance for Doubtful Accounts

•Accrued Warranty

•Income Taxes

•Share-Based Compensation

•Impairment of Long-Lived Assets

•Derivatives and Hedging Activity

•Long-Term Incentive Compensation Accrual

•Impairment of Goodwill

Please refer to the discussion of critical accounting policies in our most recent Annual Report on Form 10-K for the fiscal year ended June 27, 2020, for further details.

19

RESULTS OF OPERATIONS

Comparison of the Three Months Ended September 26, 2020 with the Three Months Ended September 28, 2019

The financial information and discussion below should be read in conjunction with the Consolidated Financial Statements and Notes.

The following table sets forth certain information regarding the components of our condensed consolidated statements of income for the three months ended September 26, 2020 as compared to the three months ended September 28, 2019. It is provided to assist in assessing differences in our overall performance (in thousands):

	Three Months Ended
	September 26, 2020			% of net sales		September 28, 2019			% of net sales		$ change		% point change
Net sales	$	123,207		100.0	%	$	105,285		100.0	%	$	17,922	—	%
Cost of sales	113,192			91.9	%	96,012			91.2	%	17,180		0.7	%
Gross profit	10,015			8.1	%	9,273			8.8	%	742		(0.7)	%
Research, development and engineering	2,245			1.8	%	1,660			1.6	%	585		0.2	%
Selling, general and administrative	4,974			4.0	%	5,074			4.8	%	(100)		(0.8)	%
Total operating expenses	7,219			5.8	%	6,734			6.4	%	485		(0.6)	%
Operating income	2,796			2.3	%	2,539			2.4	%	257		(0.1)	%
Interest expense, net	681			0.6	%	710			0.7	%	(29)		(0.1)	%
Income before income taxes	2,115			1.7	%	1,829			1.7	%	286		—	%
Income tax provision	396			0.3	%	277			0.3	%	119		—	%
Net income	$	1,719		1.4	%	$	1,552		1.5	%	$	167	(0.1)	%
Effective income tax rate	18.7		%			15.1		%

Net Sales

Net sales of $123.2 million for the first quarter of fiscal year 2021 increased by 17.0 percent as compared to net sales of $105.3 million for the first quarter of fiscal year 2020.

The $17.9 million increase in net sales from the prior year period was driven by an increase in demand for new program wins and current programs. However, partially offsetting the increase in revenue during the first quarter of fiscal year 2021, the Company’s revenue was constrained by labor shortages at its facilities in Juarez due to the COVID-19 pandemic and associated public health measures.

Gross Profit

Gross profit as a percentage of net sales for the three months ended September 26, 2020 was 8.1 percent compared to 8.8 percent for the three months ended September 28, 2019. This 0.7 percentage point decrease was due to an increase in COVID related expenses.

The level of gross margin is impacted by facility utilization, product mix, timing, severity and steepness of new program ramps, pricing within the electronics industry and material costs, which can fluctuate significantly from quarter to quarter.

Included in gross profit are charges related to changes in the allowance for obsolete inventory. We recorded a provision of approximately $178,000 and $21,000 for obsolete inventory during the three months ended September 26, 2020 and September 28, 2019, respectively. We adjust the allowance for estimated obsolescence as necessary in an amount equal to the difference between the cost of inventory and estimated net realizable value based on assumptions as to future demand and market conditions. The reserves are established for inventory that we have determined customers are not contractually responsible for and for inventory that we believe customers will be unable to purchase.

20

Operating Expenses

Total research, development, and engineering (RD&E) expenses were $2.2 million during the three months ended September 26, 2020 and $1.7 million during the three months ended September 28, 2019, respectively. The increase in RD&E expenses relate to an increase in engineering payroll expenses. Total RD&E expenses as a percent of net sales were 1.8 percent during the three months ended September 26, 2020 and 1.6 percent during the three months ended September 28, 2019.

Total selling, general and administrative (SG&A) expenses were $5.0 million during the three months ended September 26, 2020 compared to $5.1 million for the three months ended September 28, 2019. Total SG&A expenses for the three months ended September 26, 2020, were favorably impacted by a decrease in travel related expenses due to the COVID-19 pandemic. Total SG&A expenses as a percentage of net sales were 4.0 percent for the three months ended September 26, 2020 and 4.8 percent for the three months ended September 28, 2019.

Interest

Interest expense was $0.7 million during the three months ended September 26, 2020 and the three months ended September 28, 2019, respectively.

Income Taxes

The effective tax rate for the three months ended September 26, 2020 was 18.7 percent compared to 15.1 percent for the three months ended September 28, 2019. The increase was primarily due to reduced federal research and development tax credits in the three months ended September 26, 2020. For further information on taxes see footnote 6 of the “Notes to Consolidated Financial Statements.”

Our judgments regarding deferred tax assets and liabilities may change due to changes in market conditions, changes in estimates, changes in tax laws or other factors. If assumptions and estimates change in the future the deferred tax assets and liability will be adjusted accordingly and any increase or decrease will result in an additional deferred income tax expense or benefit in subsequent periods.

BACKLOG

On September 26, 2020, we had an order backlog of approximately $201.9 million. This compares with a backlog of approximately $159.9 million on September 28, 2019. The increase in order backlog was related to the effect of the COVID-19 pandemic on our customer’s demand resulting in a net positive, as the Company saw increases in demand from programs for home-consumer products, healthcare and home exercise equipment. Order backlog consists of purchase orders received for products expected to be shipped within the next 12 months, although shipment dates are subject to change due to design modifications or changes in other customer requirements. Order backlog should not be considered an accurate measure of future net sales.

21

CAPITAL RESOURCES AND LIQUIDITY

Operating Cash Flow

Net cash used in operating activities for the three months ended September 26, 2020 was $9.4 million, compared to $10.3 million during the same period of the prior fiscal year.

The $9.4 million of net cash used in operating activities for the three months ended September 26, 2020 is primarily related to $1.7 million in net income for the period adjusted for $1.8 million of depreciation and amortization, a $5.4 million increase in accounts receivable, a $4.9 million increase in inventory, a $2.8 million decrease in accrued compensation and vacation, a $1.1 million decrease in accounts payable, $0.7 million increase in contract assets. The $5.4 million increase in accounts receivable is a direct result of the Company not factoring receivables during the first quarter fiscal year 2021.

The $10.3 million of net cash used in operating activities for the three months ended September 28, 2019 is primarily related to $1.6 million in net income for the period adjusted for $1.6 million of depreciation and amortization, a $13.6 million increase in accounts payable, $0.4 million decrease in contract assets, offset by a $17.3 million increase in inventory and a $10.1 million increase in accounts receivable.

Accounts receivable fluctuates based on the timing of shipments, terms offered and collections that occurred during the quarter. While overall net sales are not typically seasonal in nature, we ship the majority of our product during the latter half of the quarter. In addition, accounts receivable will fluctuate based upon the amount of accounts receivable sold under our trade accounts receivable purchase programs. During the three months ended September 26, 2020, the Company did not factor any accounts receivable. During the three months ended September 28, 2019, we factored accounts receivable of $17.8 million, which were removed from our Consolidated Balance Sheets. The $17.8 million year over year decrease in factored receivables is a direct result of the Company not factoring receivables during the first quarter fiscal year 2021. We purchase inventory based on customer forecasts and orders, and when those forecasts and orders change, the amount of inventory may also fluctuate. Accounts payable fluctuates with changes in inventory levels, volume of inventory purchases, negotiated supplier terms and taking advantage of early pay discounts.

Investing Cash Flow

Cash used in investing activities was $3.2 million during the three months ended September 26, 2020 as compared to $1.3 million during the three months ended September 28, 2019. Our primary investing activity during the three months ended September 26, 2020 and September 28, 2019, was purchasing equipment to support increased production levels for new programs.

Leases are often utilized when potential technical obsolescence and funding requirement advantages outweigh the benefits of equipment ownership. Capital expenditures and periodic lease payments are expected to be financed with internally generated funds as well as our revolving line of credit facility and equipment term loan.

Financing Cash Flow

Cash provided by financing activities was $13.5 million during the three months ended September 26, 2020 as compared to $11.5 million in the same period of the previous fiscal year. Our primary financing activities during the three months ended September 26, 2020 and three months ended September 28, 2019, were borrowings and repayments under our revolving line of credit facility and term loans.

As of September 26, 2020, approximately $12.3 million was available under the asset-based revolving credit facility. As of September 28, 2019, approximately $13.3 million was available under the revolving line of credit facility with Wells Fargo Bank.

Our cash requirements are affected by the level of current operations and new programs. We believe that projected cash from operations, funds available under the revolving credit facility and leasing capabilities will be sufficient to meet our working and fixed capital requirements for the foreseeable future. The Company further notes the positive impact of COVID-19 on projected cash from operations from increased demand from certain customers will be partially offset by an anticipated slowdown in collections from others. As of September 26, 2020, we had approximately $825,000 of cash held by foreign subsidiaries. If cash is to be repatriated in the future from these foreign subsidiaries, the Company would be subject to certain withholding taxes in the foreign jurisdictions. The total amount of tax payments required for the amount of foreign subsidiary cash on hand as of September 26, 2020 would approximate $42,000. We have accrued withholding taxes for expected future repatriation of foreign earnings as discussed in footnote 6 of the “Notes to Consolidated Financial Statements.”

22

OFF-BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

We have included a summary of our Contractual Obligations in our annual report on Form 10-K for the fiscal year ended June 27, 2020. There have been no material changes in contractual obligations outside the ordinary course of business since June 27, 2020.

RISKS AND UNCERTAINTIES THAT MAY AFFECT FUTURE RESULTS

The following risks and uncertainties could affect our actual results and could cause results to differ materially from past results or those contemplated by our forward-looking statements. When used herein, the words “expects,” “believes,” “anticipates” and other similar expressions are intended to identify forward-looking statements.

Our operations may be subject to certain risks.

We manufacture product in facilities located in Mexico, China, Vietnam and the United States. These operations may be subject to a number of risks, including:

•difficulties in staffing, turnover and managing onshore and offshore operations;

•political and economic instability (including acts of terrorism, pandemics, civil unrest, forms of violence and outbreaks of war), which could impact our ability to ship, manufacture, and/or receive product;

•unexpected changes in regulatory requirements and laws;

•longer customer payment cycles and difficulty collecting accounts receivable;

•export duties, import controls and trade barriers (including quotas);

•governmental restrictions on the transfer of funds;

•burdens of complying with a wide variety of foreign laws and labor practices; subject to trade wars and tariffs

•our locations may be impacted by hurricanes, tornadoes, earthquakes, water shortages, tsunamis, floods, typhoons, fires, extreme weather conditions and other natural or man-made disasters. Our locations may also be impacted by future temporary closures and labor constraints as a result of COVID-19.

Our operations in certain foreign locations receive favorable income tax treatment in the form of tax credits or other incentives. In the event that such tax incentives are not extended, are repealed, or we no longer qualify for such programs, our taxes may increase, which would reduce our net income.

Additionally, certain foreign jurisdictions restrict the amount of cash that can be transferred to the U.S or impose taxes and penalties on such transfers of cash. To the extent we have excess cash in foreign locations that could be used in, or is needed by, our operations in the United States, we may incur significant penalties and/or taxes to repatriate these funds.

We may experience fluctuations in quarterly results of operations.

Our quarterly operating results have varied in the past and may vary in the future due to a variety of factors, including adverse changes in the U.S. and global macroeconomic environment, volatility in overall demand for our customers’ products, success of customers’ programs, timing of new programs, new product introductions or technological advances by us, our customers and our competitors, and changes in pricing policies by us, our customers, our suppliers, and our competitors. Our customer base is diverse in the markets they serve, however, decreases in demand, particularly from customers in certain industries could affect future quarterly results. Additionally, our customers could be adversely impacted by illiquidity in the credit markets which could directly impact our operating results.

Component procurement, production schedules, personnel and other resource requirements are based on estimates of customer requirements. Occasionally, our customers may request accelerated production that can stress resources and reduce operating margins. Conversely, our customers may abruptly lower or cancel production which may lead to a sudden, unexpected increase in inventory or accounts receivable for which we may not be reimbursed even when under contract with customers. In addition, because many of our operating expenses are relatively fixed, a reduction in customer demand can harm our gross profit and operating results. The products which we manufacture for our customers have relatively short product lifecycles. Therefore, our business, operating results and financial condition are dependent in a significant way on our ability to obtain orders from new customers and new product programs from existing customers.

Operating results can also fluctuate if changes are made to significant estimates and assumptions. Significant estimates and assumptions include the allowance for doubtful receivables, provision for obsolete and non-saleable inventory, stock-based compensation, the valuation allowance on deferred tax assets, impairment of long-lived assets, long-term incentive compensation accrual, the provision for warranty costs, and the impact of hedging activities.

23

Due to the COVID-19 pandemic, we have seen extreme shifts in demand from our customer base. The possibility of future temporary closures and labor constraints, as well as the inability to predict customer demand, costs, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results.

We are exposed to general economic conditions, which could have a material adverse impact on our business, operating results and financial condition.

Adverse economic conditions and uncertainty in the global economy such as unstable global financial and credit markets, inflation, and recession can negatively impact our business. Unfavorable economic conditions could affect the demand for our customers’ products by triggering a reduction in orders as well as a decline in forecasts which could adversely affect our sales in future periods. Additionally, the financial strength of our customers and suppliers and their ability to obtain and rely on credit financing may affect their ability to fulfill their obligations to us and have an adverse effect on our financial results.

Adverse macroeconomic conditions as a result of COVID-19 can affect our business. The conditions can affect the Company’s ability to predict and plan for future supply chain disruptions, fluctuations in customer demand and costs, and the ability to operate as there is uncertainty over future temporary closures.

The majority of our sales come from a small number of customers and a decline in sales to any of these customers could adversely affect our business.

At present, our customer base is concentrated and could become more or less concentrated. There can be no assurance that our principal customers will continue to purchase products from us at current levels. Moreover, we typically do not enter into long-term volume purchase contracts with our customers, and our customers have certain rights to extend or delay the shipment of their orders. We, however, typically require that our customers contractually agree to buy back inventory purchased within specified lead times to build their products if not used.

The loss of one or more of our major customers, or the reduction, delay or cancellation of orders from such customers, due to economic conditions or other forces, could materially and adversely affect our business, operating results and financial condition. The contraction in demand from certain industries could impact our customer orders and have a negative impact on our operations over the foreseeable future. Additionally, if one or more of our customers were to become insolvent or otherwise unable to pay for the manufacturing services provided by us, our operating results and financial condition would be adversely affected.

We depend on a limited number of suppliers for certain components that are critical to our manufacturing processes. A shortage of these components or an increase in their price could interrupt our operations and result in a significant change in our results of operations.

We are dependent on many suppliers, including sole source suppliers, to provide key components and raw materials used in manufacturing customers’ products. We have seen supply shortages in certain electronic components. In addition, our suppliers' facilities may also experience earthquakes, tsunamis and other natural disasters which may cause a shortage of components. This can result in longer lead times and the inability to meet our customers request for flexible production and extended shipment dates. If demand for components outpaces supply, capacity delays could affect future operations. Delays in deliveries from suppliers or the inability to obtain sufficient quantities of components and raw materials could cause delays or reductions in shipment of products to our customers which could adversely affect our operating results and damage customer relationships.

Key Tronic is working closely with its employees and key suppliers to ascertain delays attributable to the COVID-19 pandemic. Potential delays in production and extended transit times of critical parts may cause a shortage of components.

We operate in a highly competitive industry; if we are not able to compete effectively in the EMS industry, our business could be adversely affected.

Competitors may offer customers lower prices on certain high volume programs. This could result in price reductions, reduced margins and loss of market share, all of which would materially and adversely affect our business, operating results, and financial condition. If we were unable to provide comparable or better manufacturing services at a lower cost than our competitors, it could cause sales to decline. In addition, competitors can copy our non-proprietary designs and processes after we have invested in development of products for customers, thereby enabling such competitors to offer lower prices on such products due to savings in development costs.

Cash and cash equivalents are exposed to concentrations of credit risk.

We place our cash with high credit quality institutions. At times, such balances may be in excess of the federal depository insurance limit or may be on deposit at institutions which are not covered by insurance. If such institutions were to become insolvent during which time it held our cash and cash equivalents in excess of the insurance limit, it could be necessary to obtain other credit financing to operate our facilities.

24

Our ability to secure and maintain sufficient credit arrangements is key to our continued operations.

There is no assurance that we will be able to retain or renew our credit agreements in the future. In the event the business grows rapidly or there is uncertainty in the macroeconomic climate, additional financing resources could be necessary in the current or future fiscal years. There is no assurance that we will be able to obtain equity or debt financing at acceptable terms, or at all in the future. In addition, we have restrictive covenants with our financial institution which could impact how we manage our business. If we cannot meet our financial covenants, our borrowings could become immediately payable which could have a material adverse impact on our financial statements. For a summary of our banking arrangements, see Note 4 Long-Term Debt of the “Notes to Consolidated Financial Statements.”

Fluctuations in foreign currency exchange rates could increase our operating costs.

We have manufacturing operations located in Mexico, China and Vietnam. A portion of our operations are denominated in the Mexican peso, the Chinese renminbi (RMB) and Vietnamese dong (VND). Currency exchange rates fluctuate daily as a result of a number of factors, including changes in a country's political and economic policies. Volatility in the currencies of our entities and the United States dollar could seriously harm our business, operating results and financial condition. The primary impact of currency exchange fluctuations is on the cash, receivables, payables and expenses of our operating entities. As part of our hedging strategy, we currently use Mexican peso forward contracts to hedge foreign currency fluctuations for a portion of our Mexican peso denominated expenses. We currently do not hedge expenses denominated in RMB or VND. Unexpected losses could occur from increases in the value of these currencies relative to the United States dollar.

As a result of COVID-19, significant currency exchange fluctuations can occur causing unexpected losses. Future temporary closures of production facilities in Mexico could also cause significant changes in our ability to qualify for hedge accounting treatment of our forward contracts to hedge foreign currency fluctuations. However, given the unprecedented nature of the pandemic the FASB staff believes that an entity may apply the exception in paragraph 815-30-40-4 for rare cases caused by extenuating circumstances that are related to the nature of the forecasted transaction and are outside the control or influence of an entity to delays in the timing of the forecasted transactions if those delays are related to the effects of the COVID-19 pandemic and are considered probable to still occur. In addition, the FASB staff believes that it would be acceptable for an entity to determine that missed forecasts related to the effects of the COVID-19 pandemic need not be considered when determining whether it has exhibited a pattern of missing forecasts that would call into question its ability to accurately predict forecasted transactions and the propriety of using cash flow hedge accounting in the future for similar transactions. 

Our success will continue to depend to a significant extent on our key personnel.

Our future success depends in large part on the continued service of our key technical, marketing and management personnel and on our ability to continue to attract and retain qualified production employees. There can be no assurance that we will be successful in attracting and retaining such personnel, particularly in our manufacturing locales that may be experiencing high demand for similar key personnel. The loss of key employees could have a material adverse effect on our business, operating results and financial condition.

If we are unable to maintain our technological and manufacturing process expertise, our business could be adversely affected.

The markets for our customers’ products are characterized by rapidly changing technology, evolving industry standards, frequent new product introductions and short product life cycles. The introduction of products embodying new technologies or the emergence of new industry standards can render existing products obsolete or unmarketable. Our success will depend upon our customers’ ability to enhance existing products and to develop and introduce, on a timely and cost-effective basis, new products that keep pace with technological developments and emerging industry standards and address evolving and increasingly sophisticated customer requirements. Failure of our customers to do so could substantially harm our customers’ competitive positions. There can be no assurance that our customers will be successful in identifying, developing and marketing products that respond to technological change, emerging industry standards or evolving customer requirements.

25

Start-up costs and inefficiencies related to new or transferred programs can adversely affect our operating results and such costs may not be recoverable if such new programs or transferred programs are canceled or don’t meet expected sales volumes.

Start-up costs, the management of labor and equipment resources in connection with the establishment of new programs and new customer relationships, and the need to obtain required resources in advance can adversely affect our gross margins and operating results. These factors are particularly evident in the ramping stages of new programs. These factors also affect our ability to efficiently use labor and equipment. We are currently managing a number of new programs. Consequently, our exposure to these factors has increased. In addition, if any of these new programs or new customer relationships were terminated, our operating results could be harmed, particularly in the short term. We may not be able to recoup these start-up costs or replace anticipated new program revenues.

Customers may change production timing and demand schedules which makes it difficult for us to schedule production and capital expenditures and to maximize the efficiency of our manufacturing capacity.

Changes in demand for customer products reduce our ability to accurately estimate the future requirements of our customers. This makes it difficult to schedule production and maximize utilization of our manufacturing capacity. We must determine the levels of business that we will seek and accept from customers, set production schedules, commit to procuring inventory, and allocate personnel and resources, based on our estimates of our customers' requirements. Customers can require sudden increases and decreases in production which can put added stress on resources and reduce margins. Sudden decreases in production can lead to excess inventory on hand which may or may not be reimbursed by our customers even when under contract.

Continued growth could further lead to capacity constraints. We may need to transfer production to other facilities, acquire new facilities, or outsource production which could negatively impact gross margin. The Company has been able to manage the arrival of components in an effort to control inventory levels of customers that have seen sharp decreases in demand, as a result of COVID-19.

An adverse change in the interest rates for our borrowings could adversely affect our financial condition.

We are exposed to interest rate risk under our revolving line of credit and term loan. Refer to the discussion in note 4, "Long-Term Debt" to the consolidated financial statements for further details of our debt obligations.

Compliance or the failure to comply with current and future environmental and health laws or regulations could cause us significant expense.

We are subject to a variety of domestic and foreign environmental regulations relating to the use, storage, and disposal of materials used in our manufacturing processes. If we fail to comply with any present or future regulations, we could be subject to future liabilities or the suspension of current manufacturing operations. In addition, such regulations could restrict our ability to expand our operations or could require us to acquire costly equipment, substitute materials, or incur other significant expenses to comply with government regulations.

To protect the health of its employees, the Company has implemented the recommendations of WHO and the CDC including wearing of face masks and shields, workstation arrangements to provide social distancing, temperature monitoring, enhanced worksite disinfection, spacing in cafeterias and break areas, contact management and other precautions. The Company is also in compliance with government regulations related to COVID-19.

Our stock price is volatile.

Holders of the common stock will suffer immediate dilution to the extent outstanding equity awards are exercised to purchase common stock. Our stock price may be subject to wide fluctuations and possible rapid increases or declines over a short time period. These fluctuations may be due to factors specific to us such as our stock's thinly traded nature, variations in quarterly operating results or changes in earnings estimates, or to factors relating to the EMS industry or to the securities markets in general, which, in recent years, have experienced significant price fluctuations. These fluctuations often have been unrelated to the operating performance of the specific companies whose stocks are traded.

26

Due to inherent limitations, there can be no assurance that our system of disclosure and internal controls and procedures will be successful in preventing all errors, theft and fraud, or in informing management of all material information in a timely manner.

Management does not expect that our disclosure controls and internal controls and procedures will prevent all errors or fraud. A control system is designed to give reasonable, but not absolute, assurance that the objectives of the control system are met. In addition, any control system reflects resource constraints and the benefits of controls must be considered relative to their costs. Inherent limitations of a control system may include: judgments in decision making may be faulty, breakdowns can occur simply because of error or mistake and controls can be circumvented by collusion or management override. Due to the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.

If we do not manage our growth effectively, our profitability could decline.

Our business is experiencing growth which can place considerable additional demands upon our management team and our operational, financial and management information systems. Our ability to manage growth effectively requires us to continue to implement and improve these systems; avoid cost overruns; maintain customer, supplier and other favorable business relationships during possible transition periods; continue to develop the management skills of our managers and supervisors; and continue to train, motivate and manage our employees. Our failure to effectively manage growth could have a material adverse effect on our results of operations.

If our manufacturing processes and services do not comply with applicable statutory and regulatory requirements, or if we manufacture products containing design or manufacturing defects, demand for our services may decline and we may be subject to liability claims.

We manufacture and design products to our customers’ specifications, and, in some cases, our manufacturing processes and facilities may need to comply with applicable statutory and regulatory requirements. For example, medical devices that we manufacture or design, as well as the facilities and manufacturing processes that we use to produce them, are regulated by the Food and Drug Administration and non-U.S. counterparts of this agency. In addition, our customers’ products and the manufacturing processes that we use to produce them often are highly complex. As a result, products that we manufacture may at times contain manufacturing or design defects, and our manufacturing processes may be subject to errors or not be in compliance with applicable statutory and regulatory requirements. Defects in the products we manufacture or design, whether caused by a design, manufacturing or component failure or error, or deficiencies in our manufacturing processes, may result in delayed shipments to customers or reduced or canceled customer orders. If these defects or deficiencies are significant, our business reputation may also be damaged. The failure of the products that we manufacture or our manufacturing processes and facilities to comply with applicable statutory and regulatory requirements may subject us to legal fines or penalties and, in some cases, require us to shut down or incur considerable expense to correct a manufacturing process or facility. Our customers are required to indemnify us against liability associated with designing products to meet their specifications. However, if our customers are responsible for the defects, they may not, or may not have resources to, assume responsibility for any costs or liabilities arising from these defects, which could expose us to additional liability claims.

Energy price increases may negatively impact our results of operations.

Certain components that we use in our manufacturing process are petroleum-based. In addition, we, along with our suppliers and customers, rely on various energy sources in our transportation activities. While significant uncertainty currently exists about the future levels of energy prices, a significant increase is possible. Increased energy prices could cause an increase to our raw material costs and transportation costs. In addition, increased transportation costs related to certain suppliers and customers could be passed along to us. We may not be able to increase our product prices enough to offset these increased costs. In addition, any increase in our product prices may reduce our future customer orders and profitability.

Disruptions to our information systems, including security breaches, losses of data or outages, could adversely affect our operations.

We rely on information technology networks and systems to process, transmit and store electronic information. In particular, we depend on our information technology infrastructure for a variety of functions, including worldwide financial reporting, inventory management, procurement, invoicing and email communications. Any of these systems may be susceptible to outages due to fire, floods, power loss, telecommunications failures, terrorist attacks and similar events. Despite the implementation of network security measures, our systems and those of third parties on which we rely may also be vulnerable to computer viruses, break-ins and similar disruptions. If we or our vendors are unable to prevent such outages and breaches, our operations could be disrupted.

27

We are involved in various legal proceedings.

In the past, we have been notified of claims relating to various matters including contractual matters, intellectual property rights or other issues arising in the ordinary course of business. In the event of such a claim, we may be required to spend a significant amount of money to defend or otherwise address the claim. Any litigation or dispute resolution, even where a claim is without merit, could result in substantial costs and diversion of resources. Accordingly, the resolution or adjudication of such disputes, even those encountered in the ordinary course of business, could have a material effect on our business, consolidated financial conditions and results of operations.

Our levels of insurance coverage may not be sufficient for potential damages, claims or losses.

We have various forms of business and liability insurance which we believe are appropriate based on the needs of companies in our industry. As a result, not all of our potential business risks or potential losses would be covered by our insurance policies. If we sustain a significant claim or loss which is not covered by insurance, our net income could be negatively impacted.

Changes in securities laws and regulations will increase our costs and risk of noncompliance.

We are subject to additional requirements contained in the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act) and more recently the Dodd-Frank Act. The Sarbanes-Oxley and Dodd-Frank Acts required or will require changes in some of our corporate governance, securities disclosure and compliance practices. In response to the requirements of the Sarbanes-Oxley and Dodd-Frank Acts, the SEC and NASDAQ promulgated new rules and additional rulemaking is expected in the future. Compliance with these new rules and future rules has increased and may increase further our legal, financial and accounting costs as well as a potential risk of noncompliance. Absent significant changes in related rules, which we cannot assure, we anticipate some level of increased costs related to these new regulations to continue indefinitely. We also expect these developments to make it more difficult and more expensive to obtain director and officer liability insurance, and we may be forced to accept reduced coverage or incur substantially higher costs to obtain coverage. Likewise, these developments may make it more difficult for us to attract and retain qualified members of our Board of Directors or qualified management personnel. Further, the costs associated with the compliance with and implementation of procedures under these and future laws and related rules could have a material impact on our results of operations. In addition, the costs associated with noncompliance with additional securities laws and regulations could also impact our business.

We may encounter complications with acquisitions, which could potentially harm our business.

Any current or future acquisitions may require additional equity financing, which could be dilutive to our existing shareholders, or additional debt financing, which could potentially affect our credit ratings. Any downgrades in our credit ratings associated with an acquisition could adversely affect our ability to borrow by resulting in more restrictive borrowing terms. To integrate acquired businesses, we must implement our management information systems, operating systems and internal controls, and assimilate and manage the personnel of the acquired operations. The integration of acquired businesses may be further complicated by difficulties managing operations in geographically dispersed locations. The integration of acquired businesses may not be successful and could result in disruption by diverting management’s attention from the core business. In addition, the integration of acquired businesses may require that we incur significant restructuring charges or other increases in our expenses and working capital requirements, which reduce our return on invested capital.

Acquisitions may involve numerous other risks and challenges including but not limited to: potential loss of key employees and customers of the acquired companies; the potential for deficiencies in internal controls at acquired companies; lack of experience operating in the geographic market or industry sector of the acquired business; constraints on available liquidity, and exposure to unanticipated liabilities of acquired companies. These and other factors could harm our ability to achieve anticipated levels of profitability at acquired operations or realize other anticipated benefits of an acquisition, and could adversely affect our consolidated business and operating results.

Changes in financial accounting standards may affect our reported financial condition or results of operations as well increase costs related to implementation of new standards and modifications to internal controls.

Our consolidated financial statements are prepared in conformity with accounting standards generally accepted in the United States, or U.S. GAAP. These principles are subject to amendments made primarily by the Financial Accounting Standards Board (FASB) and the Securities and Exchange Commission (SEC). A change in those policies can have a significant effect on our reported results and may affect our reporting of transactions which are completed before a change is announced. Changes to accounting rules or challenges to our interpretation or application of the rules by regulators may have a material adverse effect on our reported financial results or on the way we conduct business.

28

Item 3.Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

We are subject to the risk of fluctuating interest rates in the normal course of business. Our major market risk relates to our secured debt. Our asset-based senior revolving credit facility and equipment financing facility are secured by substantially all of our assets. The interest rates applicable to our asset-based senior revolving credit facility fluctuate with LIBOR rates. There was outstanding $80.7 million in borrowings under our asset-based senior revolving credit facility and $4.9 million outstanding on our equipment financing facility as of September 26, 2020. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Capital Resources and Liquidity” and Note 4 – “Long-Term Debt” to the Consolidated Financial Statements for additional information regarding our revolving credit facility and term loans.

Foreign Currency Exchange Risk

A significant portion of our operations are in foreign locations. As a result, transactions occur in currencies other than the U.S. dollar. Exchange rate fluctuations among other currencies used by us would directly or indirectly affect our financial results. We currently use Mexican peso forward contracts to hedge foreign currency fluctuations for a portion of our Mexican peso denominated expenses. There was outstanding $30.0 million of foreign currency forward contracts as of September 26, 2020. The fair value of these contracts was $0.9 million. See Note 10 – “Derivative Financial Instruments” to the Consolidated Financial Statements for additional information regarding our derivative instruments.

Item 4.Controls and Procedures

It is the responsibility of our management to establish, maintain, and monitor disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 are recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms. Additionally, these disclosure controls include controls and procedures that are designed to accumulate and communicate the information required to be disclosed to our company’s Chief Executive Officer and Chief Financial Officer, allowing for timely decisions regarding required disclosures. As of the end of the period covered by this report, our management carried out an evaluation, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(f). Based on our assessment, we believe that as of September 26, 2020, the Company’s disclosure controls and procedures are effective based on that criteria.

Due to inherent limitations of any internal control system, management acknowledges that there are limitations as to the effectiveness of internal controls over financial reporting and therefore recognize that only reasonable assurance can be gained from any internal control system. Accordingly, our internal control system may not detect or prevent material misstatements in our financial statements and projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting

There have been no significant changes in our internal controls over financial reporting during the three months ended September 26, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)).

29

PART II. OTHER INFORMATION:

Item 1.Legal Proceedings

We are involved in various legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Item 1A.Risk Factors

Information regarding risk factors appear in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Item 3, “Quantitative and Qualitative Disclosures about Market Risk” of this Form 10-Q.

There are no material changes to the risk factors set forth in Part I Item 1A in the Company’s Annual Report on Form 10-K for the year ended June 27, 2020.

Item 6.	Exhibits
	31.1	Certification of Chief Executive Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)
	31.2	Certification of Chief Financial Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)
	32.1	Certification of Chief Executive Officer (18 U.S.C. 1350)
	32.2	Certification of Chief Financial Officer (18 U.S.C. 1350)
	101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
	101.SCH	XBRL Taxonomy Extension Schema Document *
	101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document *
	101.DEF	XBRL Taxonomy Extension Definition Linkbase Document *
	101.LAB	XBRL Taxonomy Extension Label Linkbase Document *
	101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document *
	104	Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extention information contained in Exhibits 101.INS, 101.SCH, 101.CAL, 101.DEF, 101.LAB and 101.PRE)

* Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities and Exchange Act of 1934, as amended and otherwise are not subject to liability under those sections.

30

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

KEY TRONIC CORPORATION
/s/    CRAIG D. GATES
Craig D. Gates	Date:	November 5, 2020
President and Chief Executive Officer
(Principal Executive Officer)
/s/    Brett R. Larsen
Brett R. Larsen	Date:	November 5, 2020
Executive Vice President of Administration, Chief Financial Officer and Treasurer
(Principal Financial Officer)

31

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Craig D. Gates, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Key Tronic Corporation;

2.Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b)Designed such control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles,

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons fulfilling the equivalent functions);

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting

Dated:	November 5, 2020
		/s/ Craig D. Gates
		Craig D. Gates
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Brett R. Larsen, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Key Tronic Corporation;

2.Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b)Designed such control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles,

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons fulfilling the equivalent functions);

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting

Dated:	November 5, 2020
		/s/ Brett R. Larsen
		Brett R. Larsen
		Executive Vice President of Administration, Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Key Tronic Corporation (the “Company”) on Form 10-Q for the period ended September 26, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Craig D. Gates, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

1.The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	November 5, 2020
		/s/ Craig D. Gates
		Craig D. Gates
		President and Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Key Tronic Corporation (the “Company”) on Form 10-Q for the period ended September 26, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Brett R. Larsen, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

1.The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	November 5, 2020
		/s/ Brett R. Larsen
		Brett R. Larsen
		Executive Vice President of Administration, Chief Financial Officer and Treasurer

XML

Document and Entity Information - shares	3 Months Ended
	Sep. 26, 2020	Nov. 03, 2020
Document Documentand Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	0-11559
Entity Registrant Name	KEY TRONIC CORP
Entity Incorporation, State or Country Code	WA
Entity Tax Identification Number	91-0849125
Entity Address, Address Line One	N. 4424 Sullivan Road
Entity Address, City or Town	Spokane Valley
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	99216
City Area Code	509
Local Phone Number	928-8000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--06-29
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	KTCC
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		10,759,680
Amendment Flag	false
Document Period End Date	Sep. 26, 2020
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000719733

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 26, 2020	Jun. 27, 2020
ASSETS
Cash and cash equivalents	$ 1,471	$ 553
Trade receivables, net of allowance for doubtful accounts of $609 and $609	91,563	86,123
Contract assets	24,458	23,753
Inventories, net	119,791	115,020
Other	18,782	17,315
Total current assets	256,065	242,764
Property, plant and equipment, net	33,316	31,764
Operating lease right-of-use assets, net	16,370	17,568
Other assets:
Deferred income tax asset	9,632	10,178
Other	2,429	2,587
Total other assets	12,061	12,765
Total assets	317,812	304,861
LIABILITIES AND SHAREHOLDERS’ EQUITY
Accounts payable	79,146	80,204
Accrued compensation and vacation	7,641	10,428
Current portion of debt, net	906	7,508
Other	13,957	14,079
Total current liabilities	101,650	112,219
Long-term liabilities:
Term loans	4,021	3,258
Revolving loan	80,414	60,094
Operating lease liabilities	11,502	12,624
Deferred income tax liability	232	234
Other long-term obligations	1,386	875
Total long-term liabilities	97,555	77,085
Total liabilities	199,205	189,304
Commitments and contingencies (Note 9)
Shareholders’ equity:
Common stock, no par value—shares authorized 25,000; issued and outstanding 10,760 and 10,760 shares, respectively	47,009	46,946
Retained earnings	71,830	70,111
Accumulated other comprehensive income (loss)	(232)	(1,500)
Total shareholders’ equity	118,607	115,557
Total liabilities and shareholders’ equity	$ 317,812	$ 304,861

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Sep. 26, 2020	Jun. 27, 2020
Statement of Financial Position [Abstract]
Trade receivables, allowance for doubtful accounts	$ 609	$ 609
Common stock - par value	$ 0	$ 0
Common stock - shares authorized	25,000	25,000
Common stock - shares issued	10,760	10,760
Common stock - shares outstanding	10,760	10,760

XML

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Income Statement [Abstract]
Net sales	$ 123,207	$ 105,285
Cost of sales	113,192	96,012
Gross profit	10,015	9,273
Operating expenses
Research, development and engineering expenses	2,245	1,660
Selling, general and administrative expenses	4,974	5,074
Total operating expenses	7,219	6,734
Operating income	2,796	2,539
Interest expense, net	681	710
Income before income taxes	2,115	1,829
Income tax provision	396	277
Net income	$ 1,719	$ 1,552
Earnings per share:
Net income per share — Basic	$ 0.16	$ 0.14
Weighted average shares outstanding — Basic	10,760	10,760
Net income per share — Diluted	$ 0.16	$ 0.14
Weighted average shares outstanding — Diluted	11,040	10,805

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Comprehensive income:
Net income	$ 1,719	$ 1,552
Other comprehensive income:
Unrealized gain (loss) on hedging instruments, net of tax	1,268	(947)
Comprehensive income	$ 2,987	$ 605

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Statement of Comprehensive Income [Abstract]
Unrealized gain (loss) on foreign exchange contracts, tax	$ 1.5	$ (0.3)

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Operating activities:
Net income	$ 1,719	$ 1,552
Adjustments to reconcile net income to cash used in operating activities:
Depreciation and amortization	1,752	1,609
Amortization of deferred loan costs	13	8
Provision for obsolete inventory	178	21
Provision for warranty	19	16
Loss on disposal of assets	0	206
Share-based compensation expense	63	74
Deferred income taxes	(81)	(360)
Changes in operating assets and liabilities:
Trade receivables	(5,449)	(10,140)
Contract assets	(705)	399
Inventories	(4,949)	(17,327)
Other assets	292	(829)
Accounts payable	(1,059)	13,643
Accrued compensation and vacation	(2,787)	600
Other liabilities	1,555	215
Cash used in operating activities	(9,439)	(10,313)
Investing activities:
Purchase of property and equipment	(3,186)	(3,046)
Proceeds from sale of fixed assets	0	696
Cash receipts from deferred purchase price of factored receivables	0	1,079
Cash used in investing activities	(3,186)	(1,271)
Financing activities:
Payment of financing costs	(307)	(2)
Proceeds from issuance of long term debt	5,000	5,000
Repayments of long term debt	10,842	1,468
Borrowings under revolving credit agreement	45,975	45,799
Repayments of revolving credit agreement	25,358	37,842
Cash provided by financing activities	13,543	11,487
Net increase (decrease) in cash and cash equivalents	918	(97)
Cash and cash equivalents, beginning of period	553	601
Cash and cash equivalents, end of period	1,471	504
Noncash investing and financing items:
Beneficial interest in transferred receivables	(9)	(1,788)
Supplemental cash flow information:
Interest payments	578	593
Income tax payments, net of refunds	351	213
Payments for Hedge, Financing Activities	$ (925)	$ 0

XML

CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive (Loss) Income
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balances (Shares)		10,760
Balances, Period Start at Jun. 29, 2019	$ 114,459	$ 46,680	$ 65,353	$ 2,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock appreciation rights (Shares)		0
Share-based compensation expense	74	$ 74
Net income	1,552		1,552
Unrealized gain (loss) on hedging instruments, net	(947)			(947)
Balances, Period End at Sep. 28, 2019	115,138	$ 46,754	66,905	1,479
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balances (Shares)		10,760
Balances (Shares)		10,760
Balances, Period Start at Jun. 27, 2020	115,557	$ 46,946	70,111	(1,500)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock appreciation rights (Shares)		0
Share-based compensation expense	63	$ 63
Net income	1,719		1,719
Unrealized gain (loss) on hedging instruments, net	1,268			1,268
Balances, Period End at Sep. 26, 2020	$ 118,607	$ 47,009	$ 71,830	$ (232)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balances (Shares)		10,760

XML

BASIS OF PRESENTATION

3 Months Ended

Sep. 26, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION

Basis of PresentationThe consolidated financial statements included herein have been prepared by Key Tronic Corporation and subsidiaries (the Company) pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in our annual consolidated financial statements have been condensed or omitted. The year-end condensed consolidated balance sheet information was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 27, 2020.

FISCAL YEAR

The Company’s reporting period is a 52/53 week fiscal year ending on the Saturday closest to June 30. The three month period ended September 26, 2020 and September 28, 2019, were 13 week periods. Fiscal year 2021 will end on July 3, 2021, which is a 53 week year. Fiscal year 2020 which ended on June 27, 2020, was a 52 week year.

Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)

Due to the COVID-19 pandemic, the Company has seen extreme shifts in demand from its customer base. The possibility of future temporary closures, as well as adverse fluctuations in customer demand, freight and expedite costs, precautionary safety expenses and labor shortages, collectability of accounts, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results. Additionally, continued adverse macroeconomic conditions and significant currency exchange fluctuations can also materially impact operating results.

XML

SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Sep. 26, 2020

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

Significant Accounting Policies

Earnings Per Common Share

Basic earnings per common share (EPS) is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing net income (loss) by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of equity awards were used to repurchase common shares at the average market price during the period. The computation of diluted EPS does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on EPS.

Derivative Instruments and Hedging Activities

The Company has entered into foreign currency forward contracts that are accounted for as cash flow hedges in accordance with ASC 815, “Derivatives and Hedging”. The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative’s effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item.

The Company uses derivatives to manage the variability of foreign currency fluctuations of expenses in our Mexico facilities. The foreign currency forward contracts have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded.

The Company’s foreign currency forward contracts potentially expose the Company to credit risk to the extent the counterparty may be unable to meet the terms of the agreement. The Company minimizes such risk by utilizing a counterparty with a strong credit rating. The Company’s counterparty to the foreign currency forward contracts is a major banking institution. This institution does not require collateral for the contracts, and the Company believes that the risk of the counterparty failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes.

Income Taxes

We compute our interim income tax provision through the use of an estimated annual effective tax rate (ETR) applied to year-to-date operating results and specific events that are discretely recognized as they occur. In determining the estimated annual ETR, we analyze various factors, including projections of our annual earnings, taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, our ability to use tax credits and available tax planning alternatives. Discrete items, including the effect of changes in tax laws, tax rates, and certain circumstances with respect to valuation allowances or other unusual or non-recurring tax adjustments, are reflected in the period in which they occur as an addition to, or reduction from, the income tax provision, rather than included in the estimated annual ETR.

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized.

We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. The tax years 1998 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject. Refer to Note 6 for further discussions.

Recently Issued Accounting Standards

In March of 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments, which clarifies specific issues raised by stakeholders. Specifically, the ASU clarifies the following: 1) that all entities are required to provide the fair value option disclosures in ASC 825, Financial Instruments 2) clarifies that the portfolio exception in ASC 820, Fair Value Measurement, applies to nonfinancial items accounted for as derivatives under ASC 815, Derivatives and Hedging; 3) clarifies that for purposes of measuring expected credit losses on a net investment in a lease in accordance with ASC 326, Financial Instruments - Credit Losses, the lease term determined in accordance with ASC 842, Leases, should be used as the contractual term; 4) clarifies that when an entity regains control of financial assets sold, it should recognize an allowance for credit losses in accordance with ASC 326; and 5) aligns the disclosure requirements for debt securities in ASC 320, Investments - Debt Securities, with the corresponding requirements for depository and lending institutions in ASC 942, Financial Services - Depository and Lending. The amendments in the ASU have various effective dates and transition requirements which are dependent on timing of adoption of ASU 2016-13. The Company is currently assessing the effects on its consolidated financial statements, and it intends to adopt the guidance as they become effective.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), which modifies certain provisions of ASC 740, Income Taxes, in an effort to reduce the complexity of accounting for income taxes. ASU 2019-12 is effective for the Company the first quarter of fiscal year 2022. We are currently evaluating the effects and do not believe this standard will have a material impact on our consolidated financial position, results of operations, or cash flows.

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance is effective for the Company beginning in the first quarter of fiscal year 2024 with early adoption permitted. The Company is currently assessing the impact on its consolidated financial statements, and it intends to adopt the guidance when it becomes effective in the first quarter of fiscal year 2024.

XML

INVENTORIES

3 Months Ended

Sep. 26, 2020

Inventory Disclosure [Abstract]

INVENTORIES

Inventories

The components of inventories consist of the following (in thousands):

	September 26, 2020		June 27, 2020
Finished goods	$	15,632	$	15,269
Work-in-process	21,418		17,390
Raw materials and supplies	82,741		82,361
	$	119,791	$	115,020

Total inventory as of September 26, 2020 is net of $14.5 million of reserves, customer payments, and customer deposits compared to $17.3 million in reserves, customer payments, and customer deposits as of June 27, 2020.

XML

LONG-TERM DEBT

3 Months Ended

Sep. 26, 2020

Debt Disclosure [Abstract]

LONG-TERM DEBT

Long-Term Debt

On August 14, 2020, the Company entered into a loan agreement with Bank of America. The Loan Agreement replaces the Company’s prior amended and restated credit agreement, as amended, with Wells Fargo Bank. The Loan Agreement provides for a five-year asset-based senior secured revolving credit facility of up to $93 million, maturing on August 14, 2025. As of September 26, 2020, the Company had an outstanding balance under the asset-based revolving credit facility of $80.7 million and $12.3 million available for future borrowings.

As of June 27, 2020, the Company had an outstanding balance under the credit facility with Wells Fargo Bank of $60.1 million, $0.4 million in outstanding letters of credit and $4.5 million available for future borrowings. The Company had an outstanding balance of $10.0 million under the term loan with Wells Fargo Bank as of June 27, 2020.

On August 14, 2020, the Company also entered into a $5.0 million equipment financing facility relating to the Company’s existing U.S. manufacturing equipment that bears interest at 4.85% and matures on August 14, 2025. Under this loan agreement, equal monthly payments of approximately $94,000 commenced on September 14, 2020 and will continue through the maturity of the equipment financing facility on August 14, 2025. As of September 26, 2020, the Company had an outstanding balance of $4.9 million. As of June 27, 2020, the Company had an outstanding balance of $0.9 million under the Wells Fargo Bank equipment term loan agreement.

The interest rates on outstanding debt as of September 26, 2020 range from 3.00% - 4.85% compared to 2.17% - 2.18% as of June 27, 2020.

Generally, the interest rate applicable to loans under the loan agreement will be, at the Company’s option: (i)(A) the base rate which is the highest of (1) the prime rate for the applicable day (as such rate is determined from time to time by the Bank), (2) the federal funds rate for the applicable day plus 0.50%, and (3) LIBOR for a 30-day interest period as of the applicable day plus 1.00% (provided that in no event shall the base rate be less than zero), plus the applicable interest margin for base rate loans; and (B) LIBOR rate for an applicable interest period (provided that in no event shall the LIBOR rate be less than 0.50%), plus the applicable interest margin for LIBOR rate loans. Depending on average daily excess borrowing availability over applicable periods under the Credit Facility, applicable interest margins on: (x) base rate loans will be 1.25-1.75%; and (y) LIBOR rate loans will be 2.25-2.75%, resetting on a quarterly basis beginning in early 2021. If there is an event of default under the loan agreement, all loans and other obligations will bear interest at a rate of an additional 2.00% on the otherwise applicable interest rates. In addition to interest charges, the Company is required to pay a fee of 0.25% per annum on the unused portion of the Credit Facility, monthly in arrears.

Under the new loan agreement with Bank of America, the asset-based revolving credit facility bears interest at LIBOR plus 2.5%, as elected by the Company.

Debt maturities as of September 26, 2020 for the next five years and thereafter are as follows (in thousands):

Fiscal Years Ending	Amount
2021 (1)	$	678
2022	943
2023	989
2024	1,039
2025	1,090
Thereafter	80,899
Total debt	$	85,638
Unamortized debt issuance costs	(297)
Long-term debt, net of debt issuance costs	$	85,341

    (1) Represents scheduled payments for the remaining nine-month period ending July 3, 2021.

The Company must comply with certain financial covenants, including a fixed charge coverage ratio and a cash flow leverage ratio. The credit agreement requires the Company to grant certain inspection rights to the Bank, limit or restrict the Company’s cash management; limit or restrict the ability of the Company to incur additional liens, make acquisitions or investments, incur additional indebtedness, engage in mergers, consolidations, liquidations, dissolutions, or dispositions, pay dividends or other restricted payments, prepay certain indebtedness, engage in transactions with affiliates, and use proceeds. The Company was in compliance with all financial covenants as of September 26, 2020.

XML

TRADE ACCOUNTS RECEIVABLE PURCHASE PROGRAMS

3 Months Ended

Sep. 26, 2020

Receivables [Abstract]

TRADE ACCOUNTS RECEIVABLE PURCHASE PROGRAMS

Trade Accounts Receivable Purchase Programs

Sale Programs

The Company has utilized an Account Purchase Agreement with Wells Fargo Bank, N.A. (“WFB”) which allowed the Company to sell and assign to WFB and WFB to purchase from the Company the accounts receivable of certain Company customers in a maximum aggregate amount outstanding of $25.0 million. As of September 26, 2020, the Company had no factored receivables with WFB.

The Company did not sell any accounts receivables during the three months ended September 26, 2020. Total accounts receivables sold during the three months ended September 28, 2019 was approximately $17.8 million. Accounts receivables sold and not yet collected was $9,000 as of June 27, 2020. The receivables that were sold were removed from the condensed consolidated balance sheets and the cash received is reflected as cash provided by operating activities in the condensed consolidated statements of cash flows. Cash receipts related to the deferred purchase price from receivables factored by the Company is reflected as cash provided by investing activities.

XML

INCOME TAXES

3 Months Ended

Sep. 26, 2020

Income Tax Disclosure [Abstract]

INCOME TAXES

Income Taxes

The Company expects to repatriate a portion of its foreign earnings based on increased net sales growth driving additional capital requirements domestically, cash requirements for potential acquisitions and to implement certain tax strategies. The Company currently expects to repatriate approximately $8.0 million of foreign earnings in the future. All other unremitted foreign earnings are expected to remain permanently reinvested for planned fixed assets purchases and improvements in foreign locations.

Repatriations of cash will generally be tax-free in the U.S. However, withholding taxes in China may still apply to any such future repatriations. Management has not changed its indefinite investment assertions with regard to the portion of accumulated earnings and profits in China that may be repatriated in the future. Accordingly, management estimates that future repatriations of cash from China may result in approximately $0.8 million of withholding tax. There would be no offsetting foreign tax credits in the U.S. and as such, this potential liability is a direct cost associated with actual repatriations. Withholding taxes will not apply to future repatriations from Mexico or Vietnam.

The Company has available approximately $8.7 million of gross federal research and development tax credits as of September 26, 2020. ASC 740 requires the Company to recognize in its financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. Accordingly, as of September 26, 2020, the Company has recorded $2.9 million of unrecognized tax benefits associated with these federal tax credits, resulting in a net deferred tax benefit of approximately $5.8 million.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits net operating loss (NOL) carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The Company does not expect that the NOL carryback provision of the CARES Act will result in a material cash benefit. In addition, the CARES Act contains modifications on the limitation of business interest for tax years beginning in 2019 and 2020. The modifications to Section 163(j) increase the allowable business interest deduction from 30% of adjusted taxable income to 50% of adjusted taxable income. This modification (in connection with related modifications included in final regulations issued in the first quarter of fiscal year 2021) would increase the allowable interest expense deduction of the Company and result in less taxable income for fiscal years 2020 and 2021, but is not expected to have a material impact on the provision for income taxes. Also, under the CARES Act, AMT credits not previously refunded for the 2018 tax year are refundable in the 2019 taxable year rather than in years 2019-2021, and taxpayers can elect to claim 100% of the AMT credits in the first taxable year beginning in 2018 by applying for a tentative refund claim on or before December 31, 2020. The Company made this election by applying for a tentative refund claim in the fourth quarter of fiscal year 2020. The Company is continuing to evaluate the impacts of other aspects of the CARES Act, and at this time the Company does not believe they will have a material impact on our consolidated financial position, results of operations, or cash flows.

XML

EARNINGS PER SHARE

3 Months Ended

Sep. 26, 2020

Earnings Per Share [Abstract]

EARNINGS PER SHARE

Earnings Per Share

The following table presents a reconciliation of the denominator in the basic and diluted EPS calculation and the number of antidilutive common share awards that were not included in the diluted earnings per share calculation. These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period.

	Three Months Ended
	(in thousands, except share and per share information)
	September 26, 2020		September 28, 2019
Net income	$	1,719	$	1,552
Weighted average shares outstanding—basic	10,760		10,760
Effect of dilutive common stock awards	280		45
Weighted average shares outstanding—diluted	11,040		10,805
Net income per share—basic	$	0.16	$	0.14
Net income per share—diluted	$	0.16	$	0.14
Antidilutive SARs not included in diluted earnings per share	329		940

XML

SHARE-BASED COMPENSATION

3 Months Ended

Sep. 26, 2020

Share-based Payment Arrangement [Abstract]

SHARE BASED COMPENSATION

Share-based Compensation

The Company’s incentive plan provides for equity and liability awards to employees and non-employee directors in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold, research, development and engineering, and selling, general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations.

In addition to service conditions, SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are evaluated quarterly to determine the likelihood that performance metrics will be achieved during the performance period. These awards are charged to compensation expense over the requisite service period based on the number of shares expected to vest. The SARs cliff vest after a three-year period from date of grant and expire five years from date of grant.

The grant date fair value for the awards granted below were estimated using the Black Scholes option valuation method:

	July 23, 2020		July 26, 2019
SARs Granted	155,000		175,000
Strike Price	$	6.94	$	4.93
Fair Value	$	2.32	$	1.23

Total share-based compensation expense recognized during the three months ended September 26, 2020 and September 28, 2019 was approximately $64,000 and $74,000, respectively.

As of September 26, 2020, total unrecognized compensation expense related to unvested share-based compensation arrangements was approximately $0.5 million. This expense is expected to be recognized over a weighted average period of 2.33 years. No SARs were exercised during the three months ended September 26, 2020 or September 28, 2019.

XML

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Sep. 26, 2020

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

Commitments and Contingencies

Litigation and Other Matters

The Company is party to certain lawsuits or claims in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the financial position, results of operations or cash flow of the Company.

Warranties

The Company provides warranties on certain product sales. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. If actual return rates and/or repair and replacement costs differ significantly from management’s estimates, adjustments to recognize additional cost of sales may be required in future periods. The Company’s warranty reserve was approximately $13,000 as of September 26, 2020 and $15,000 as of June 27, 2020, respectively.

XML

DERIVATIVE FINANCIAL INSTRUMENTS

3 Months Ended

Sep. 26, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE FINANCIAL INSTRUMENTS

Derivative Financial Instruments

As of September 26, 2020, the Company had outstanding foreign currency forward contracts with a total notional amount of $30.0 million. The maturity dates for these contracts extend through December 2021. For the three months ended September 26, 2020, the Company did not enter into any foreign currency forward contracts and settled $6.7 million of contracts. During the same period of the previous year, the Company did not enter into any foreign currency forward contracts and settled $6.7 million of contracts.

As of September 26, 2020, the aggregate notional amount of the Company’s outstanding foreign currency contracts along with their unrealized gains (losses) are expected to mature as summarized below (in thousands):

Quarter Ending	Notional Contracts in MXN		Notional Contracts in USD		Estimated Fair Value
December 26, 2020	$	132,773	$	6,241	$	(333)
April 3, 2021	$	148,253	$	6,682	$	(161)
July 3, 2021	$	144,725	$	6,446	$	(134)
October 2, 2021	$	146,373	$	5,502	$	805
January 1, 2022	$	137,973	$	5,129	$	754

On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of September 30, 2022, related to the borrowings outstanding under the term loan with Wells Fargo Bank. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.70% that replaces the one month LIBOR rate component of our contractual interest to be paid to Wells Fargo Bank as part of our term loan. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the term loan, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. At date of termination this interest rate swap was in a liability position of $148,400, which will be amortized to interest expense over the original term of the swap.

On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of November 1, 2023, related to the borrowings outstanding under the line of credit with Wells Fargo Bank. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.67% that replaces the one month LIBOR rate component of our contractual interest to be paid to Wells Fargo Bank as part of our line of credit. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the line of credit, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. At date of termination this interest rate swap was in a liability position of $776,500, which will be amortized to interest expense over the original term of the swap.

The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of September 26, 2020 and June 27, 2020 (in thousands):

		September 26, 2020		June 27, 2020
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value		Fair Value
Foreign currency forward contracts	Other current assets	$	771	$	—
Foreign currency forward contracts	Other long-term assets	$	788	$	1,097
Foreign currency forward contracts	Other current liabilities	$	(628)	$	(1,960)
Foreign currency forward contracts	Other long-term liabilities	$	—	$	(17)
Interest rate swap	Other current liabilities	$	—	$	(347)
Interest rate swap	Other long-term liabilities	$	—	$	(610)

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended September 26, 2020 and September 28, 2019, respectively (in thousands):

Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of June 27, 2020		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of September 26, 2020
Forward contracts	Cost of sales	$	(759)	$	1,043	$	359	$	643
Interest rate swap	Interest expense	(741)		(223)		89		(875)
Total		$	(1,500)	$	820	$	448	$	(232)
Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of June 29, 2019		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of September 28, 2019
Forward contracts	Cost of sales	$	2,424	$	(41)	$	(904)	$	1,479
Interest rate swap	Interest expense	2		—		(2)		—
Total		$	2,426	$	(41)	$	(906)	$	1,479

As of September 26, 2020, the net amount of unrealized gain expected to be reclassified into earnings within the next 12 months is approximately $0.1 million. As of September 26, 2020, the Company does not have any foreign exchange contracts with credit-risk-related contingent features.

XML

FAIR VALUE MEASUREMENTS

3 Months Ended

Sep. 26, 2020

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

Fair Value MeasurementsThe Company currently has forward contracts to hedge known future cash outflows for expenses denominated in the Mexican peso. These contracts are measured on a recurring basis based on the foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. There are three levels of fair value hierarchy inputs used to value assets and liabilities which include: Level 1 – inputs are quoted market prices for identical assets or liabilities; Level 2 – inputs other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – inputs are unobservable inputs for the asset or liability. These contracts are marked to market using level 2 input criteria every quarter with the unrealized gain or loss, net of tax, reported as a component of shareholders’ equity in accumulated other comprehensive gain (loss), as they qualify for hedge accounting.

The following table summarizes the fair value of assets (liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of September 26, 2020 and June 27, 2020 (in thousands):

	September 26, 2020
	Level 1		Level 2		Level 3		Total Fair Value
Financial Assets:
Foreign currency forward contracts	$	—	$	1,559	$	—	$	1,559
Financial Liabilities:
Foreign currency forward contracts	$	—	$	(628)	$	—	$	(628)

	June 27, 2020
	Level 1		Level 2		Level 3		Total Fair Value
Financial Assets:
Foreign currency forward contracts	$	—	$	1,097	$	—	$	1,097
Financial Liabilities:
Interest rate swap	$	—	$	(957)	$	—	$	(957)
Foreign currency forward contracts	$	—	$	(1,977)	$	—	$	(1,977)

The carrying values of cash and cash equivalents, accounts receivable and current liabilities reflected on the balance sheets at September 26, 2020 and June 27, 2020, reasonably approximate their fair value. The Company’s long-term debt, which is measured at amortized cost, primarily consists of an asset-based revolving credit facility, lease liability, and an equipment loan. These borrowings bear interest at LIBOR plus 2.5% per the loan agreement. Each of these rates is a variable floating rate dependent upon current market conditions and the Company’s current credit risk as discussed in footnote 4.

As a result of the determinable market rates for our asset-based revolving credit facility and equipment loan, they are classified within Level 2 of the fair value hierarchy. Further, the carrying value of each of these instruments reasonably approximates their fair value as of September 26, 2020 and June 27, 2020.

XML

REVENUE

3 Months Ended

Sep. 26, 2020

Revenue from Contract with Customer [Abstract]

REVENUE FROM CONTRACT WITH CUSTOMER

Revenue

Revenue Recognition

The Company specializes in services ranging from product manufacturing to engineering and tooling services. The first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outlines the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the Company considers its contract with a customer to be the combination of the MSA and the purchase order. The transaction price is fixed and set forth in each purchase order. In the Company's normal course of business, there are no variable pricing components, or material amounts refunded to customers in the form of refunds or rebates.

The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed.

The Company’s typical payment terms are 30 to 90 days and its sales arrangements do not contain any significant financing component for its customers.

The Company generally provides a warranty for workmanship on its manufacturing contracts. Historically, the amount of returns for workmanship issues has been de minimis under the Company’s warranties.

The Company elected to not disclose information about remaining performance obligations as they are part of contracts that that have expected durations of one year or less.

During the first quarter of fiscal year 2021, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods.

Contract Balances

A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice for payment. Contract assets are classified separately on the condensed consolidated balance sheet and transferred to receivables when the right to payment becomes unconditional. The following table summarizes the activity in the Company’s contract assets during the three months ended September 26, 2020 (in thousands):

	Contract Assets
Beginning balance, June 27, 2020	$	23,753
Revenue recognized	120,783
Amounts collected or invoiced	(120,078)
Ending balance, September 26, 2020	$	24,458

Disaggregation of Revenue

The following table presents the Company’s revenue disaggregated for the three months ended September 26, 2020 and September 28, 2019 (in thousands):

	EMS Revenue
Recognition	Three Months Ended
	September 26, 2020		September 28, 2019
Over-Time	$	120,836	$	104,026
Point-in-Time	2,371		1,259
Total	$	123,207	$	105,285

XML

LEASES LEASES

3 Months Ended

Sep. 26, 2020

Leases [Abstract]

LESSEE, OPERATING LEASES

Leases

The Company has several commitments under operating leases for warehouses, manufacturing facilities, office buildings, and equipment with initial terms that expire at various dates during the next 1 year to 11 years.

The components of lease cost for the three months ended September 26, 2020 were (in thousands): 

Lease cost	Classification	Three Months Ended
Operating lease cost	Cost of sales	$	1,164
Operating lease cost	Selling, general and administrative expenses	338
Total lease cost		$	1,502

Amounts reported in the Consolidated Balance Sheet as of September 26, 2020 were (in thousands, except weighted average lease term and discount rate):

	September 26, 2020
Operating Leases:
Operating lease right of use assets	$	16,370
Operating lease liabilities (1)	16,050
Weighted-average remaining lease term (in years)
Operating leases	6.54
Weighted-average discount rate
Operating leases	4.1		%

(1) The current portion of the total operating lease liabilities of $4.5 million is classified under Other Current Liabilities, resulting in $11.5 million classified under Operating Lease Liabilities in the Long-term Liabilities section of the condensed consolidated balance sheet.

Other information related to leases was as follows (in thousands):

	Three Months Ended
	September 26, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	1,198

Future lease payments under non-cancellable leases as of September 26, 2020 are as follows (in thousands):

Fiscal Years Ending	Operating Leases
2021 (1)	$	3,073
2022	3,373
2023	2,598
2024	2,004
2025	1,894
Thereafter	5,673
Total undiscounted lease payments	18,615
Less: present value discount	(2,565)
Total lease liabilities	$	16,050

(1) Represents estimated lease payments for the remaining nine-month period ending July 3, 2021.

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Sep. 26, 2020

Accounting Policies [Abstract]

Earnings Per Common Share

Earnings Per Common Share

Basic earnings per common share (EPS) is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing net income (loss) by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of equity awards were used to repurchase common shares at the average market price during the period. The computation of diluted EPS does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on EPS.

Derivative Instruments and Hedging Activities

Derivative Instruments and Hedging Activities

The Company has entered into foreign currency forward contracts that are accounted for as cash flow hedges in accordance with ASC 815, “Derivatives and Hedging”. The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative’s effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item.

The Company uses derivatives to manage the variability of foreign currency fluctuations of expenses in our Mexico facilities. The foreign currency forward contracts have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded.

The Company’s foreign currency forward contracts potentially expose the Company to credit risk to the extent the counterparty may be unable to meet the terms of the agreement. The Company minimizes such risk by utilizing a counterparty with a strong credit rating. The Company’s counterparty to the foreign currency forward contracts is a major banking institution. This institution does not require collateral for the contracts, and the Company believes that the risk of the counterparty failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes.

Income Taxes

Income Taxes

We compute our interim income tax provision through the use of an estimated annual effective tax rate (ETR) applied to year-to-date operating results and specific events that are discretely recognized as they occur. In determining the estimated annual ETR, we analyze various factors, including projections of our annual earnings, taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, our ability to use tax credits and available tax planning alternatives. Discrete items, including the effect of changes in tax laws, tax rates, and certain circumstances with respect to valuation allowances or other unusual or non-recurring tax adjustments, are reflected in the period in which they occur as an addition to, or reduction from, the income tax provision, rather than included in the estimated annual ETR.

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized.

We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. The tax years 1998 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject. Refer to Note 6 for further discussions.

Recently Issued Accounting Standards

Recently Issued Accounting Standards

In March of 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments, which clarifies specific issues raised by stakeholders. Specifically, the ASU clarifies the following: 1) that all entities are required to provide the fair value option disclosures in ASC 825, Financial Instruments 2) clarifies that the portfolio exception in ASC 820, Fair Value Measurement, applies to nonfinancial items accounted for as derivatives under ASC 815, Derivatives and Hedging; 3) clarifies that for purposes of measuring expected credit losses on a net investment in a lease in accordance with ASC 326, Financial Instruments - Credit Losses, the lease term determined in accordance with ASC 842, Leases, should be used as the contractual term; 4) clarifies that when an entity regains control of financial assets sold, it should recognize an allowance for credit losses in accordance with ASC 326; and 5) aligns the disclosure requirements for debt securities in ASC 320, Investments - Debt Securities, with the corresponding requirements for depository and lending institutions in ASC 942, Financial Services - Depository and Lending. The amendments in the ASU have various effective dates and transition requirements which are dependent on timing of adoption of ASU 2016-13. The Company is currently assessing the effects on its consolidated financial statements, and it intends to adopt the guidance as they become effective.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), which modifies certain provisions of ASC 740, Income Taxes, in an effort to reduce the complexity of accounting for income taxes. ASU 2019-12 is effective for the Company the first quarter of fiscal year 2022. We are currently evaluating the effects and do not believe this standard will have a material impact on our consolidated financial position, results of operations, or cash flows.

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance is effective for the Company beginning in the first quarter of fiscal year 2024 with early adoption permitted. The Company is currently assessing the impact on its consolidated financial statements, and it intends to adopt the guidance when it becomes effective in the first quarter of fiscal year 2024.

Maximum Amount Of Income Tax Benefits Percentage Realized Upon Ultimate Settlement

50.00%

XML

INVENTORIES (Tables)

3 Months Ended

Sep. 26, 2020

Inventory Disclosure [Abstract]

Components of Inventories

The components of inventories consist of the following (in thousands):

	September 26, 2020		June 27, 2020
Finished goods	$	15,632	$	15,269
Work-in-process	21,418		17,390
Raw materials and supplies	82,741		82,361
	$	119,791	$	115,020

Total inventory as of September 26, 2020 is net of $14.5 million of reserves, customer payments, and customer deposits compared to $17.3 million in reserves, customer payments, and customer deposits as of June 27, 2020.

XML

LONG-TERM DEBT (Tables)

3 Months Ended

Sep. 26, 2020

Debt Disclosure [Abstract]

Schedule of Maturities of Long-term Debt

Debt maturities as of September 26, 2020 for the next five years and thereafter are as follows (in thousands):

Fiscal Years Ending	Amount
2021 (1)	$	678
2022	943
2023	989
2024	1,039
2025	1,090
Thereafter	80,899
Total debt	$	85,638
Unamortized debt issuance costs	(297)
Long-term debt, net of debt issuance costs	$	85,341

    (1) Represents scheduled payments for the remaining nine-month period ending July 3, 2021.

XML

EARNINGS PER SHARE (Tables)

3 Months Ended

Sep. 26, 2020

Earnings Per Share [Abstract]

Reconciliation of Denominator and Number of Antidilutive Common Share Awards not Included in Diluted Earnings Per Share Calculation

These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period.

	Three Months Ended
	(in thousands, except share and per share information)
	September 26, 2020		September 28, 2019
Net income	$	1,719	$	1,552
Weighted average shares outstanding—basic	10,760		10,760
Effect of dilutive common stock awards	280		45
Weighted average shares outstanding—diluted	11,040		10,805
Net income per share—basic	$	0.16	$	0.14
Net income per share—diluted	$	0.16	$	0.14
Antidilutive SARs not included in diluted earnings per share	329		940

XML

SHARE-BASED COMPENSATION (Tables)

3 Months Ended

Sep. 26, 2020

Share-based Payment Arrangement [Abstract]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

The grant date fair value for the awards granted below were estimated using the Black Scholes option valuation method:

	July 23, 2020		July 26, 2019
SARs Granted	155,000		175,000
Strike Price	$	6.94	$	4.93
Fair Value	$	2.32	$	1.23

XML

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Sep. 26, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

As of September 26, 2020, the aggregate notional amount of the Company’s outstanding foreign currency contracts along with their unrealized gains (losses) are expected to mature as summarized below (in thousands):

Quarter Ending	Notional Contracts in MXN		Notional Contracts in USD		Estimated Fair Value
December 26, 2020	$	132,773	$	6,241	$	(333)
April 3, 2021	$	148,253	$	6,682	$	(161)
July 3, 2021	$	144,725	$	6,446	$	(134)
October 2, 2021	$	146,373	$	5,502	$	805
January 1, 2022	$	137,973	$	5,129	$	754

Summerized Fair Value of Derivative Instruments in Consolidated Balance Sheets

The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of September 26, 2020 and June 27, 2020 (in thousands):

		September 26, 2020		June 27, 2020
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value		Fair Value
Foreign currency forward contracts	Other current assets	$	771	$	—
Foreign currency forward contracts	Other long-term assets	$	788	$	1,097
Foreign currency forward contracts	Other current liabilities	$	(628)	$	(1,960)
Foreign currency forward contracts	Other long-term liabilities	$	—	$	(17)
Interest rate swap	Other current liabilities	$	—	$	(347)
Interest rate swap	Other long-term liabilities	$	—	$	(610)

Gain (Loss) of Derivative Instruments in Statement of Operations

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended September 26, 2020 and September 28, 2019, respectively (in thousands):

Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of June 27, 2020		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of September 26, 2020
Forward contracts	Cost of sales	$	(759)	$	1,043	$	359	$	643
Interest rate swap	Interest expense	(741)		(223)		89		(875)
Total		$	(1,500)	$	820	$	448	$	(232)
Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of June 29, 2019		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of September 28, 2019
Forward contracts	Cost of sales	$	2,424	$	(41)	$	(904)	$	1,479
Interest rate swap	Interest expense	2		—		(2)		—
Total		$	2,426	$	(41)	$	(906)	$	1,479

XML

FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Sep. 26, 2020

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table summarizes the fair value of assets (liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of September 26, 2020 and June 27, 2020 (in thousands):

	September 26, 2020
	Level 1		Level 2		Level 3		Total Fair Value
Financial Assets:
Foreign currency forward contracts	$	—	$	1,559	$	—	$	1,559
Financial Liabilities:
Foreign currency forward contracts	$	—	$	(628)	$	—	$	(628)

	June 27, 2020
	Level 1		Level 2		Level 3		Total Fair Value
Financial Assets:
Foreign currency forward contracts	$	—	$	1,097	$	—	$	1,097
Financial Liabilities:
Interest rate swap	$	—	$	(957)	$	—	$	(957)
Foreign currency forward contracts	$	—	$	(1,977)	$	—	$	(1,977)

XML

REVENUE (Tables)

3 Months Ended

Sep. 26, 2020

Revenue from Contract with Customer [Abstract]

Contract with Customer, Asset and Liability

Contract Balances

A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice for payment. Contract assets are classified separately on the condensed consolidated balance sheet and transferred to receivables when the right to payment becomes unconditional. The following table summarizes the activity in the Company’s contract assets during the three months ended September 26, 2020 (in thousands):

	Contract Assets
Beginning balance, June 27, 2020	$	23,753
Revenue recognized	120,783
Amounts collected or invoiced	(120,078)
Ending balance, September 26, 2020	$	24,458

Disaggregation of Revenue

Disaggregation of Revenue

The following table presents the Company’s revenue disaggregated for the three months ended September 26, 2020 and September 28, 2019 (in thousands):

	EMS Revenue
Recognition	Three Months Ended
	September 26, 2020		September 28, 2019
Over-Time	$	120,836	$	104,026
Point-in-Time	2,371		1,259
Total	$	123,207	$	105,285

XML

LEASES (Tables)

3 Months Ended

Sep. 26, 2020

Leases [Abstract]

Lease, Cost

The components of lease cost for the three months ended September 26, 2020 were (in thousands): 

Lease cost	Classification	Three Months Ended
Operating lease cost	Cost of sales	$	1,164
Operating lease cost	Selling, general and administrative expenses	338
Total lease cost		$	1,502

Assets and Liabilities, Lessee

Amounts reported in the Consolidated Balance Sheet as of September 26, 2020 were (in thousands, except weighted average lease term and discount rate):

	September 26, 2020
Operating Leases:
Operating lease right of use assets	$	16,370
Operating lease liabilities (1)	16,050
Weighted-average remaining lease term (in years)
Operating leases	6.54
Weighted-average discount rate
Operating leases	4.1		%

(1) The current portion of the total operating lease liabilities of $4.5 million is classified under Other Current Liabilities, resulting in $11.5 million classified under Operating Lease Liabilities in the Long-term Liabilities section of the condensed consolidated balance sheet.

Other information related to leases was as follows (in thousands):

	Three Months Ended
	September 26, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	1,198

Lessee, Operating Lease, Liability, Maturity

Future lease payments under non-cancellable leases as of September 26, 2020 are as follows (in thousands):

Fiscal Years Ending	Operating Leases
2021 (1)	$	3,073
2022	3,373
2023	2,598
2024	2,004
2025	1,894
Thereafter	5,673
Total undiscounted lease payments	18,615
Less: present value discount	(2,565)
Total lease liabilities	$	16,050

(1) Represents estimated lease payments for the remaining nine-month period ending July 3, 2021.

XML

Inventories (Components Of Inventories) (Detail) - USD ($) $ in Thousands	Sep. 26, 2020	Jun. 27, 2020
Inventory Disclosure [Abstract]
Finished goods	$ 15,632	$ 15,269
Work-in-process	21,418	17,390
Raw materials and supplies	82,741	82,361
Inventories	119,791	115,020
Inventory Valuation Reserves	$ 14,500	$ 17,300

XML

Long-Term Debt (Detail) - USD ($)	3 Months Ended
	Sep. 26, 2020	Aug. 14, 2020	Jun. 27, 2020
Debt Disclosure [Line Items]
Increase in revolving line of credit		$ 93,000,000
Line of Credit Facility, Amount Outstanding	$ 80,700,000		$ 60,100,000
Additional availability of line of credit	12,300,000		4,500,000
Letters of Credit Outstanding, Amount			$ 400,000
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate			4.85%
2021 (1)	678,000
2022	943,000
2023	989,000
2024	1,039,000
2025	1,090,000
Thereafter	80,899,000
Total debt	85,638,000
Unamortized debt issuance costs	(297,000)
Long-term debt, net of debt issuance costs	85,341,000		$ 10,000,000.0
Equipment Term Loan
Debt Disclosure [Line Items]
Debt Instrument, Periodic Payment, Principal	94,000
Long-term debt, net of debt issuance costs	$ 4,900,000	$ 5.0	$ 900,000
Debt Instrument, Basis Spread on Variable Rate, 2.00% | Line of Credit | Fixed Rate
Debt Disclosure [Line Items]
Variable rate on line of credit facility (percent)	2.50%
Minimum
Debt Disclosure [Line Items]
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate	3.00%		2.17%
Maximum
Debt Disclosure [Line Items]
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate	4.85%		2.18%

XML

Trade Accounts Receivable Purchase Programs (Detail) - USD ($)	3 Months Ended
	Sep. 28, 2019	Sep. 26, 2020	Jun. 27, 2020
Receivables [Abstract]
Account Purchase Agreement Maximum Aggregate Amount		$ 25,000,000.0
Trade Accounts Receivable Sold To Third Party	$ 17,800,000
Accounts Receivable Factored To Banking Institutions			$ 9,000

XML

Income Taxes (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 26, 2020	Jun. 27, 2020
Income Tax Disclosure [Abstract]
Foreign tax credits related to future repatriations of earnings	$ 8,000
Estimated Federal And State Income Taxes And Potential Withholding Taxes		$ 800
Gross potential research and development (R&D) tax credit	8,700
Unrecognized tax benefits associated with federal tax credits	2,900
Deferred Tax Assets, Tax Credit Carryforwards	$ 5,800

XML

Earnings Per Share (Reconciliation Of Denominator And Number Of Antidilutive Common Share Awards Not Included In Diluted Earnings Per Share Calculation) (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Earnings Per Share [Abstract]
Net income	$ 1,719	$ 1,552
Weighted average shares outstanding - basic	10,760	10,760
Effect of dilutive common stock options (Shares)	280	45
Weighted average shares outstanding - Diluted	11,040	10,805
Net income per share—diluted	$ 0.16	$ 0.14
Net income per share—diluted	$ 0.16	$ 0.14
Antidilutive options not included in diluted earnings per share (Shares)	329	940

XML

Share-Based Compensation (Detail) - USD ($)			3 Months Ended
	Jul. 24, 2020	Jul. 25, 2019	Sep. 26, 2020	Sep. 28, 2019	Jul. 23, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Share-based Compensation Expense			$ 500,000
Unrecognized Share-based Compensation, Period for Recognition			2 years 3 months 29 days
Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
SARs Granted	155,000	175,000
Strike Price		$ 4.93			$ 6.94
Fair Value	$ 2.32	$ 1.23
Share-based Compensation Expense			$ 64,000	$ 74,000

XML

Commitments And Contingencies (Detail) - USD ($)	Sep. 26, 2020	Jun. 27, 2020
Commitments and Contingencies Disclosure [Abstract]
Warranty reserve	$ 13,000	$ 15,000

XML

Derivative Financial Instruments (Detail) - USD ($) $ in Millions	3 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Nov. 06, 2019
Derivative [Line Items]
Derivative, Notional Amount	$ 30.0
Foreign currency forward contracts entered	0.0	$ 0.0
Foreign currency forward contracts settled	6.7	$ 6.7
Derivative, Fixed Interest Rate			1.70%
Net amount of existing losses expected to be reclassified into earnings within the next 12 months	$ 0.1
Line of Credit
Derivative [Line Items]
Derivative, Fixed Interest Rate			1.67%

XML

Schedule of Derivative Instruments (Detail) - USD ($) $ in Thousands	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 26, 2020	Sep. 26, 2020
Derivative [Line Items]
Derivative, Notional Amount						$ 30,000
Subsequent Event [Member]
Derivative [Line Items]
Derivative, Fair Value, Net	$ 754	$ 805	$ (134)	$ (161)	$ (333)
Subsequent Event [Member] | Mexico, Pesos
Derivative [Line Items]
Derivative, Notional Amount	137,973	146,373	144,725	148,253	132,773
Subsequent Event [Member] | United States of America, Dollars
Derivative [Line Items]
Derivative, Notional Amount	$ 5,129	$ 5,502	$ 6,446	$ 6,682	$ 6,241

XML

Derivative Financial Instruments (Summarized Fair Value Of Derivative Instruments In Consolidated Balance Sheets) (Detail) - USD ($) $ in Thousands	Sep. 26, 2020	Jun. 27, 2020
Foreign currency forward contracts | Other current assets
Derivative Instruments [Line Items]
Foreign currency forward contracts, Asset Fair Value	$ 771	$ 0
Foreign currency forward contracts | Other long-term assets
Derivative Instruments [Line Items]
Foreign currency forward contracts, Asset Fair Value	788	1,097
Foreign currency forward contracts | Other current liabilities
Derivative Instruments [Line Items]
Foreign currency forward contracts, Liability Fair Value	628	1,960
Foreign currency forward contracts | Other long-term liabilities
Derivative Instruments [Line Items]
Foreign currency forward contracts, Liability Fair Value	0	17
Interest rate swap | Other current liabilities
Derivative Instruments [Line Items]
Foreign currency forward contracts, Liability Fair Value	0	347
Interest rate swap | Other long-term liabilities
Derivative Instruments [Line Items]
Foreign currency forward contracts, Liability Fair Value	$ 0	$ 610

XML

Derivative Financial Instruments (Gain (Loss) Of Derivative Instruments In Statement Of Operations) (Detail) - Designated As Hedging Instrument - USD ($) $ in Thousands	3 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]
AOCI Balance, Period Start	$ (1,500)	$ 2,426
Effective Portion Recorded In AOCI	820	(41)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	448	(906)
AOCI Balance, Period End	(232)	1,479
Foreign currency forward contracts
Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]
AOCI Balance, Period Start	(759)	2,424
Effective Portion Recorded In AOCI	1,043	(41)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	359	(904)
AOCI Balance, Period End	643	1,479
Interest rate swap
Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]
AOCI Balance, Period Start	(741)	2
Effective Portion Recorded In AOCI	(223)	0
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	89	(2)
AOCI Balance, Period End	$ (875)	$ 0

XML

Fair Value Measurements (Assets And Liabilities Measured At Fair Value On Recurring Basis) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 26, 2020	Jun. 27, 2020
Foreign currency forward contracts
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, Fair Value Disclosure	$ 1,559	$ 1,097
Financial and Nonfinancial Liabilities, Fair Value Disclosure	628	(1,977)
Foreign currency forward contracts | Fair Value, Inputs, Level 1 [Member]
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, Fair Value Disclosure	0	0
Financial and Nonfinancial Liabilities, Fair Value Disclosure	0	0
Foreign currency forward contracts | Fair Value, Inputs, Level 2 [Member]
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, Fair Value Disclosure	1,559	1,097
Financial and Nonfinancial Liabilities, Fair Value Disclosure	628	(1,977)
Foreign currency forward contracts | Fair Value, Inputs, Level 3 [Member]
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, Fair Value Disclosure	0	0
Financial and Nonfinancial Liabilities, Fair Value Disclosure	$ 0	0
Interest rate swap
Fair Value, Option, Quantitative Disclosures [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure		(957)
Interest rate swap | Fair Value, Inputs, Level 1 [Member]
Fair Value, Option, Quantitative Disclosures [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure		0
Interest rate swap | Fair Value, Inputs, Level 2 [Member]
Fair Value, Option, Quantitative Disclosures [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure		(957)
Interest rate swap | Fair Value, Inputs, Level 3 [Member]
Fair Value, Option, Quantitative Disclosures [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure		$ 0
Debt Instrument, Basis Spread on Variable Rate, 2.00% | Fixed Rate | Line of Credit
Fair Value, Option, Quantitative Disclosures [Line Items]
Variable rate on line of credit facility (percent)	2.50%

XML

Revenue Contract with Customer, Asset and Liability (Detail) $ in Thousands	3 Months Ended
	Sep. 26, 2020 USD ($)
Revenue from Contract with Customer [Abstract]
Beginning balance, June 30, 2019	$ 23,753
Revenue recognized	120,783
Amounts collected or invoiced	(120,078)
Ending balance, September 26, 2020	$ 24,458

XML

Revenue Disaggregation of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Disaggregation of Revenue [Line Items]
Net sales	$ 123,207	$ 105,285
Over-Time
Disaggregation of Revenue [Line Items]
Net sales	120,836	104,026
Point-in-Time
Disaggregation of Revenue [Line Items]
Net sales	$ 2,371	$ 1,259

XML

Leases (Detail) $ in Thousands	3 Months Ended
	Sep. 26, 2020 USD ($)
Lessee, Lease, Description [Line Items]
Lease, Cost	$ 1,502
Minimum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	1 year
Maximum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	11 years
Cost of Sales
Lessee, Lease, Description [Line Items]
Operating Lease, Cost	$ 1,164
Selling, General and Administrative Expenses
Lessee, Lease, Description [Line Items]
Operating Lease, Cost	$ 338

XML

Assets and Liabilities, Lessee (Detail) - USD ($) $ in Thousands	Sep. 26, 2020	Jun. 27, 2020
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets, net	$ 16,370	$ 17,568
Total lease liabilities	$ 16,050
Operating Lease, Weighted Average Remaining Lease Term	6 years 6 months 14 days
Operating Lease, Weighted Average Discount Rate, Percent	4.10%
Other current liabilities
Lessee, Lease, Description [Line Items]
Total lease liabilities	$ 4,500
Other Long Term Liabilities
Lessee, Lease, Description [Line Items]
Total lease liabilities	$ 11,500

XML

Lessee, Operating Lease, Liability, Maturity (Detail) $ in Thousands	Sep. 26, 2020 USD ($)
Lessee, Operating Lease, Liability, Maturity [Abstract]
2021 (1)	$ 3,073
2022	3,373
2023	2,598
2024	2,004
2025	1,894
Thereafter	5,673
Lessee, Operating Lease, Liability, to be Paid, Total	18,615
Less: present value discount	(2,565)
Operating Lease, Liability, Total	$ 16,050